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Abstract 
The active antimalarial principles of three traditional medicinal plants, Passerina 
obtusifolia (Thymelaeaceae), Tetradenia riparia (Labiatea) and Xerophyta retinervis 
(V elloziaceae) were investigated by employing bioassay guided fractionation. Two 
novel compounds and five known constituents were isolated from the active fractions 
of these three plants. 
The types of compounds isolated included: three triterpenoids (20(29)-Lupene-3a,28-
diol (30), 20(29)-Lupene-3a, 16~,28-triol (32) and 3 ~-Hydroxy-20(29)-Lupen-28-oic 
acid (42)); two diterpenoids (8-Abietene-7~,13~-diol (45) and cariocal (51)); one 
flavonoid ( 5-Hydroxy:.4' ,6, 7-trimethoxyflavone ( 44)) and one flavonolignan ( 11-0-
acetyl hydnocarpin (62)). In addition, one analogue of 7a-hydroxyroyleanone (41) 
(which was previously isolated from T riparia and was found to be the active 
antimalarial principle of the plant) was prepared. 
Flash chromatography and column chromatography techniques were central in the 
isolation of the compounds. Structural· elucidation included the use of HREIMS and 
various ID and 2D NMR spectroscopy such as 1H, 13C, COSY, HMQC, HMBC and 
NOESY spectroscopy. Complete and unambiguous assignments of the 1H and 13C 
NMR spectra were possible for all the compounds isolated. In addition, antimalarial 
activity was tested for all the compounds isolated and prepared. ICso values were 
reported for all these compounds. 
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CHAPTER I 
INTRODUCTION 
1.1. Objectives 
The objectives of this project were to isolate, purify and identify the active antimalarial 
principles from the extracts of three traditional medicinal plants: Passerina obtusif o/ia, 
Tetradenia riparia and Xerophyta retinervis, using a bioassay guided fractionation 
procedure. 
The rest of the introduction section will be divided into three sections: in the first 
section, the reasons for studying natural products and in particular those from 
traditional medicinal plants, as well as the general approach in the search for bioactive · 
plant constituents will be briefly discussed. · In the second section, the techniques used· 
in this study for identifying the structure of various compounds isolated from the plants 
will be briefly discussed with emphasis on the Nuclear Magnetic Resonance (NMR) 
Spectroscopy and the strategy for analysing the various ID and 2D NMR spectra in 
the identification of structure. Finally, in the third section, the disease, malaria, with 
historical background, the various drugs used as treatment for the disease and the 
urgency for developing new antimalarial drugs will be ~iscussed. Also, the approaches 
in the search for new antimalarials in recent years will be demonstrated with examples. 
In addition, there will be a short summary on the bioassays employed in this study for 
evaluating the antimalarial activity. 
1.2. Traditional Medicine, Plant Natural Products and the Search for New Drugs 
The plant kingdom has in the past been referred to as "the sleeping giant of drug 
development". Chinese medicine makes a great use of natural products with some 
5600 plant-derived medicines listed in the Chinese Pharmacopoeia. In India, 
Ayurvedic, Siddha and Unani medicine is likewise dependent on plants, to the extent of 
about 2300 species. It has been estimated that about 80 % of the world's population 
2 
population rely on various traditional medical systems, all of which use plant-derived 
remedies. In South Africa, it appears that 70 - 80 % of African people visit traditional 
doctors on a regular basis and use the locally available herbal preparations 
prescribed 1• 
The plant derived pharmaceuticals that constitute 30 % of prescription drugs used in 
the western medical systems are obtained from only about 120 plant species. The 
potential of higher plants as sources for new drugs is still largely unexplored. Among 
the estimated 250 000 - 500 000 plant species, only a small percentage have been 
investigated phytochemically and the fraction submitted to biological or 
pharmacological screening is even smaller2• 
Natural products provide the oldest source for new medicine. Natural selection during 
evolution and competition between the species, has produced powerful biologically 
active natural products which can serve as chemical leads, to be refined by the chemist 
to give more specifically active drugs. For example, moulds and bacteria produce 
substances that prevent other org3!1isms from growing in their vicinity. The famous 
Penicillium mould led to the considerable range of semisynthetic penicillins, and gave 
rise to the concept of seeking naturally occurring antibiotics3. 
Another fruitful means of identifying pharmacologically active natural products has 
been the traditional remedies, which are mainly plant products. The wealth of 
information from African traditional healers provides a meaningful starting point. It 
has been shown that plants used in traditional medicine are more likely to yield 
pharmacologically active compounds: for example, in the field of anticancer activity, 
a correlation between confirmed biological activity and use in traditional medicine has 
been demonstrated4' 5• 
c 
3 
The following are a few examples of important medicines that are derived from 
plants6: 
1) alkaloids, such as codeine (1), for example, which is a common ingredient of 
syrups used to suppress an irritating cough or of analgesic preparations taken to 
relieve various aches and pains. This compound is isolated from the opium poppy, 
Papaver somniferum. Morphine (2), also from the same plant, is a more potent 
analgesic than codeine, with additional sedative properties; 
1 2 
2) The steroid diosgenin (3), a starting material for the snythesis of the first 
contraceptive pill, was discovered in wild yams from Mexico and Guatemala. 
Today, more than 3000 other plants derivatives are used around the world for 
birth control; 
I • 
3 
•. 3'-· ~ 
4 
3) Reserpine ( 4) has been used as a treatment for hypertension for nearly 30 years in 
the West but the shrub that produces it has been used in herbal tranquillisers for 
millennia; 
N 
H 
o~ 
4 
4) Sodium cromoglycate (5), the active component of Intal, the most commercially 
successful drug for treating asthma, was developed from substances extracted from 
a Mediterranean plant used since ancient times for the treatment of colic; 
0 o~o 0 
OH~ 
5 
5) Pilocarpine (6) is an alkaloid which comes from Pilocarpine jaborandi. It is used 
in the treatment of glaucoma; 
6 
5 
6) Nabilone (7) is an antiemetic derived from Cannabis sativa (marijuana); 
0 
7 
7) Quinine (8), isolated from an extract of bark of the cinchona tree, was the original 
treatment for malaria and remains the drug of choice for celebral and other 
complicated forms of malaria. 
MeO 
8 
Amongst various research efforts in this field, a systematic evaluation of the southern 
African flora was initiated at Noristan (Pty, Ltd) in 1974 with the aim of isolating and 
• 
identifying pharmacologically useful compounds. To preserve this rapidly 
disappearing knowledge, more than 40 000 reports on the medicinal uses of plants 
have been collected and stored in a computer data base7• 
6 
1.3. Strategy in the Search for Bioactive Plant Constituents 
The following steps are normally involved in the process that leads from the plant to a 
pharmacologically active pure constituent8: 
1. collection, proper botanical identification and drying of the bio-active plant 
material: the selection of plants is based on the leads from traditional medicine or 
information from databases and field work may also be useful; 
2. preparation of appropriate extracts in which water, dichloromethane, petroleum 
ether and ethanol are the solvents commonly used; 
3. biological and pharmacological screening of crude extracts in order to identify 
active extracts for further evaluation; 
4. chemical screening of crude extracts by combined analytical techniques such as 
LC/UV, LC/MS and LC/NMR where available. These hyphenated techniques 
allow the early recognition of common compounds in the extract and at the same 
time, the localization of interesting new ones; 
5. several consecutive steps of chromatographic separation, where each fraction 
obtained has to be submitted to bioassay in order to follow the activity (bioassay-
guided fractionation); 
6. verification of the purity of the isolated compounds; 
7. structure elucidation of pure compounds by chemical and physicochemical methods; 
8. partial or total synthesis as to confirm structures; 
7 
9. preparation of derivatives/analogues for the investigation of structure-activity 
relationships; 
10. large-scale isolation of the pure compound for further pharmacological and 
toxicological tests. 
8 
1.4. Structure Determination 
After a plant constituent has been isolated and purified, it should be subjected to 
various tests in order to determine the class of compound and then to find out which 
particular compound it is within that class. First of all, its homogeneity must be 
carefully checked by means of TLC. The class of compound is often obvious from its 
response to colour tests, its solubility, Rr properties and UV spectral characteristics. 
Biochemical tests may also be applied. 
Other properties of the compound have to be measured in order to identify its 
structure completely. These properties include melting point (for solid compounds), 
boiling point (for liquid compounds), [a. ]0 and Rr. Also, its spectroscopic data, 
including UV, IR, NMR and MS measurements are useful when compared with those 
in the literature. A known compound can usually be identified on the above basis. If 
authentic material is available, direct comparison can be carried out in order to 
confirm the structure. Otherwise, careful comparison with literature data may be 
sufficient for its identification. In the case of identifying new compounds, chemical 
degradation and synthesis can be used to confirm the identification. When a known 
compound is isolated, it is necessary to confirm the agreement of its spectroscopic 
assignments with the literature data, particularly where newer high-resolution 
instruments and techniques allow for unambiguous assignments. 
X-ray crystallography has also become widely used in identification of new plant 
compounds. This technique can be employed when the compound is obtained in 
sufficient amount and in crystalline form. It is particularly useful in determining the 
relative, and in some cases absolute stereochemistry of complex natural products9. 
9 
1.4.1. Nuclear Magnetic Resonance Spectroscopy (NMR) 
The first commercial NMR spectrometer was made in 1953. Because of the need for 
higher resolution and sensitivity, 200 - 500 MHz instruments are now routinely used10, 
and 800 MHz instruments are also available. NMR spectroscopy is of vital importance 
in the study of natural products chemistry. By careful investigation of one- and two-
dimensional NMR spectra, it is now possible to assign the complete structures of 
complex molecules based only on NMR. The advantage ofNMR spectroscopy is that 
the sample can be recovered completely and non-destructively after the experiment. 
With the modem high resolution instruments and techniques, sample amounts of less 
than 1 mg can produce well defined spectra within reasonable time-spans. 
Some of the NMR experiments commonly employed in the study of natural products 
will be briefly discussed11•1Z13: 
One-Dimensional Techniques 
The most widely used nuclei utilized in 1-D NMR spectroscopy in organic chemistry 
are 
1H and 13C. The positions of the signals, i.e. chemical shift o values, in the 1-D 
spectra are dependent on the chemical environment of the respective nucleus while 
spin-spin coupling between neighbouring nuclei gives rise to characteristic splitting of 
signals, the magnitude of which provides information on connectivities between nuclei 
and dihedral angles. Therefore the identity of any functional group present can readily 
be deduced, together with bonding patterns in molecular fragments. 
13C NMR spectrometry has been available on a practical basis only since the early 
1970's. The 12C nucleus has a spin number (I) of zero, and only the 13C nucleus 
(1=1/2) can be observed in NMR spectrometry. Since the natural abundance of 13C is 
only 1.1 % that of 12C, NMR experiments involving excitation of 13C nucleus require 
many more scans in order to obtain a useful spectrum than are necessary in the 1H 
NMR experiments. Several techniques which enhance the sensitivity of 13C NMR. 
spectrometry are available. One example is the removal of 13C-1H coupling which 
( 
10 
simplifies the 13C spectrum and also improves the sensitivity of the nucleus through 
Nuclear Overhauser Enhancement (NOE). 
Trends in chemical shifts (8) of 13C are somewhat parallel to those of 1H. The 13C 
shifts are related mainly to hybridization and substituent electronegativity, whereas in 
1H NMR spectroscopy, electronegativity (inductive effects), electron delocalization 
and diamagnetic anisotropy are the main factors to be considered. 
The 13C spectrum normally gives better signal separation due to the wider range of 
chemical shifts involved and the spectrum is also much simpler to interpret. Usually, 
the total number of carbons present in a molecule can be obtained by simply counting 
the number of signals in 13C spectrum unless overlapping signals are encountered. 
Besides the conventional one-dimensional 13C NMR spectroscopy, a number of 
multiple pulse experiments which enable distinction between quaternary, tertiary, 
secondary and primary carbons have been developed. Two of the most commonly 
used techniques are the APT (Attached Proton Test) and DEPT (Distortionless 
Enhancement by Polarisation Transfer). 
Two-Dimensional Techniques 
One-dimensional NMR spectrometry alone can not afford sufficient information for 
characterising an unknown compound completely. Two-dimensional spectra play an 
important role in structure elucidation as they yield a large number of spin correlations 
present within one molecule. Many 2D experiments are available, and a brief 
discussion will be given for those most frequently used: 
11 
COSY (1H-1H Homonuclear Shift Correlation Spectroscopy) 
This is the most commonly used 2-D experiment. This experiment yields two 1-D 1H 
spectra which can be plotted at right angles to each other to give a COSY contour.plot. 
The diagonal of this plot represents the 1 H NMR spectrum. Cross-peaks are observed 
for scalar coupled protons with significant coupling constants. It is therefore possible 
to trace a spin system and obtain sub-structures. 1H-1H COSY not only provides 
information for unambiguous 1H NMR assignments but also helps in 13C NMR 
assignments via 1H-13C COSY spectrum. Other variants of COSY are also useful, for 
example: the phase sensitive COSY (PS-COSY) is used in establishing remote 
connectivities, as the COSY cross-peaks display the entire coupling information 
concerning the protons involved. Double-quantum filtered COSY (DQF-COSY) 
spectra are used for visualisation of cross-peaks which are close to diagonal. Triple-
quantum filtered COSY (TQF-COSY) spectra eliminate all the spin systems that 
contain less than three or more mutually coupled spins. The shortcoming of COSY is 
that cross-peaks cannot be seen if the coupling constants between scalar coupled 
protons are too small (usually less than 1 Hz). Although it is sometimes possible to 
observe long-range coupling (i.e. W coupling), meta-coupling (in an aromatic ring), 
and allylic coupling. 
NOESY (2D Nuclear Overhauser) 
The NOESY experiment is a useful assignment aid which detects NOE's between 
nearby protons (3A or closer) in a molecule. Therefore through space relationships 
can be recognized. This is very useful in confirming the stereochemistry in a complex 
molecule. In a 2D NOESY spectrum, cross-peaks are observed between proton pairs 
that are close in space. However, care must be taken when interpreting the results of a 
NOESY spectrum as due to inappropriate choice of parameters, deceptive results can 
12 
be obtained. In addition, NOE peaks are often not observed for rapid tumbling 
molecules of intermediate size. 
COSY and NOESY are both homonuclear correlation techniques as they both only 
show the relationships between protons in a molecule. Several heteronuclear 
correlation spectroscopic techniques are available, and a brief discussion to some of 
these techniques will be given here. 
HETCOR (Heteronuclear Correlation Spectroscopy) 
It is the 13C-'H correlated spectroscopy which provides connectivities between 13C 
and 1 H signals and therefore allow the number of hydrogen atoms attached to each 
individual 13C atom to be deduced. In a HETCOR spectrum, cross-peaks are observed 
between the frequencies of the carbons and their directly attached protons, thus 
allowing information from one spectrum to help in the assignment of the other 
spectrum. In the axis where the 13C spectrum is displayed only the protonated carbon 
signals are detectable. 
Long Range HETCOR 
The long range HETCOR experiment detects connectivities mediated by two- or 
thret?-bond couplings and therefore provides information about the connectivity 
patterns of protonated carbons and their neighbours. 
HMQC (Heteronuclear Multiple Quantum Coherence) 
HMQC is equivalent to HETCOR which is the basic 13C-detected heteronuclear 
correlation experiment. However, HETCOR suffers from the disadvantage of low 
sensitivity due to the low natural abundance of 13C. HMQC is an inverse-detection 
2D NMR technique where heteronuclear chemical shift correlation is achieved via 
proton detection, therefore requiring a much smaller sample size to produce a useful 
spectrum within shorter experiment time. B~<;>th HETCOR and HMQC experiments 
13 
result in a two-dimentional data matrix, where the cross-peaks show correlations 
between carbon and protons which are linked. 
HMBC (Heteronuclear Multiple Bond Correlation) 
HMBC is the 1H-detected alternative of Long-Range HETCOR. The contour plot of 
the 2D matrix obtained shows two-, three- or four-bond correlations between protons 
and carbons, therefore the linkage positions in a molecule can be determined. 
The applications of the above mentioned 1-D and 2-D techniques will be illustrated in 
the following strategy. 
1.4.2. Strategy in NMR Spectroscopic Analysis 
The following steps are often involved in the elucidation of structures: 
1) the chemical shift data from the 1 H and 13C NMR spectra allows the identification 
of certain functional groups present, and in addition; the number of signals in the 
13C spectrum gives the total number of carbons present in the molecule; 
2) the DEPT spectrum gives proton-carbon coupling patterns and therefore confirms 
the pattern of proton substitution; 
3) the COSY spectrum aids the analysis of the 1H NMR spectrum from which 
coupling information reveals through-bond connectivities between protons. 
Mainly two- and three-bond couplings and occasionally four- or five-bond 
couplings can be observed, and the magnitude of couplings gives information on 
the relative spatial orientation of protons. Therefore, the relationship between 
protonated carbons can be established, this leads to the establishment of spin 
systems and postulating of sub-structures; 
14 
4) the HMQC spectrum reveals one-bond proton-carbon connectivities which leads to 
the assignment of all the protonated carbons; 
5) the HMBC spectrum gives information on two-, three- or four-bond couplings,, and 
therefore confirms th~ relationships established by the 1H and COSY spectra, the 
various sub-structures can also be connected by analysing the HMBC spectrum. It 
is particularly useful in establishing connectivities of protonated carbon atoms to 
quaternary centres, and the relationship between isolated 1H-1H spin systems in 
molecules; 
6) finally, the NOESY spectrum reveals through space interactions present m a 
molecule, enabling the assignment of relative stereochemistry. 
15 
1.5. Malaria: A Background 
Malaria is an infectious disease transmitted by female mosquitoes of the genus 
Anopheles. It is caused by minute parasite protozoa of the genus Plasmodium, which 
infect human and insect hosts altemately14. 
Four species of Plasmodium infect man. Three may cause severe illness, as the 
parasite destroys red blood cells in peripheral capillaries, thus causing anaemia, but are 
rarely fatal. These are the types of malaria which cause distinctive intermittent fevers, 
and a patient's temperature chart is a reliable guide to diagnosis. The bouts of fever 
correspond to the reproductive cycle of the parasite. These three species are: I . 
Plasmodium vivax; 2. Plasmodium ovale and 3. Plasmodium malariae. The most 
dangerous is the fouth species, Plasmodium falciparum. In this case, the infected red 
blood cells become sticky and form clumps in the capillaries of the deep organs of the 
body and cause microcirculatory arrest. This results in brain delirium, coma and 
convulsion, and death may ensue within a few days15• 
Plasmodium falciparum is the most common malaria parasite m Africa. It is 
particularly dangerous to children between the age of one to five, and to travellers 
from temperate areas. Indigenous adults are protected by a form of partial immunity 
called premunition, which limits Plasmodium multiplication but does not clear the body 
of parasites: the infected person and the parasite achieve a fragile equilibrium. This 
develops slowly and only in response to continuous exposure to infection by a specific 
species of Plasmodium. 
Malaria exists throughout most of Africa and in a wide range of environments. 
Transmission of malaria is extremely intensive in Africa with high rates of re·infection 
and super·infection. In some parts of Tanzania people receive as many as 300 infective 
bites a year from parasite·carrying mosquitoes 16. 
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Debilitation, malnutrition, enlargement of the spleen and anaemia are the expected 
complications of repeated attacks of malaria. The majority of schoolchildren in some 
endemic areas can be found to have enlargement of the spleen. The risks of chronic 
malaria are greatest for children, whose growth and development may be seriously and 
irreversibly impaired. Chronic malaria is more than a threat to individuals, as serious 
genetic blood disorders increase in populations stressed by endemic malaria. Sickle-
cell disease and thalassaemia are the most common. 
Malarial Parasite and the Mosquitoes as Vectors 
The vital discovery that mosquitoes transmit malaria was made at the end of the 
nineteenth century. Alphonse Laveran, a young doctor in the French army in 
Constantine, in Algeria, discovered that the condition is due to members of a family of 
protozoa! parasites named Plasmodium which enter red blood corpuscles when in the 
human blood stream. Later, Sir Patrick Manson, a leading specialist in tropical 
diseases in London, while working in China, found evidence that this parasite was 
carried by mosquitoes and that people became infected when bitten. These ideas were 
confirmed by Ronald Ross, a doctor in the Indian Medical Service, and announced in 
1898. In 1902, he received the Nobel prize. 
Quinine and Other Quinoline and Acrodine Derivatives as Antimalarial Agents 
The first important event in the history of malaria was the discovery of the "Peruvian 
fever tree", Cinchona. The bark of the Cinchona tree was used in South America by 
the indigenous people for the treatment of fevers. In the early seventeenth century, an 
Augustinian monk who had lived in Peru, Father Antonio de la Calancha introduced 
Cinchona bark into Europe and it proved to be very effective in the treatment of 
malaria. Cinchona bark must be one of the most successful of all herbal remedies and 
illustrates the value of traditional medicine. In 1820, Pelletier and Caventou isolated 
the active antimalarial principle: quinine (8), from Cinchona bark and found it to be 
more potent than the powdered Cinchona bark. The chemical structure of quinine was 
\ 
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elucidated in 1908, and Woodward and Doering achieved the key steps in its total 
synthesis in 1944 17• 
Meo 
8 
All other antimalarials have come from pharmacological research in this century, 
often stimulated by .the medical problems of war. During 1920s a synthetic quinoline 
derivative, pamaquin (9) was found to be more effective than quinine in killing 
malarial parasite lodged in the liver. Also mepacrine (10) was developed as a 
synthetic alternative to quinine. Further research led to the production of chloroquine 
(11) which has fewer side effects. Primaquine (12) is another quinoline derivative 
with antimalarial activity particularly effective against P. vivax, the cause of benign 
tertian fever. A biquinidine compound proguanil (13) also has powerful antimalarial 
properties but is more generally used as a prophylactic. A pyrimidine derivative, 
pyrimethamine (14), is used for suppression when used alone, for treatment it is used 
in combination with other antimalarials15• Mefloquine (15) is another effective 
synthetic antimalarial compound. 
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During the Second World War only the penicillin project had greater investment than 
the development of antimalarials. The number of compounds synthesized and tested as 
antimalarials exceeded a quarter of a million, and at least the same number of 
compounds has been tested since 194514. Unfortunately, only those mentioned above 
proved suitable for general use. 
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Proguanil, pyrimethamine and related drugs act by inhibiting folic acid metabolism 
much more strongly in the parasite than in the host. The development of the parasite 
is inhibited by these drugs, which arrest maturation, producing large, non-viable 
organisms. The effect is exactly the same as folic acid or vitamin B12 deficiency has 
on human erythrocyte maturation. The mechanism of action of other groups of 
antimalarials is obscure. Chloroquine forms complexes with the heamatin of malaria 
pigment, causing it to aggregate into coarse granules. Quinine and related drugs cause 
some clumping of pigment, also producing nuclear and cytoplasmic degeneration. 
Some of these drugs can interact with Plasmodium nucleic acids by intercalation 
where the drug molecules slide between the stacked bases of the nucleic acid therefore 
distorting its structure 14• 
Most drugs for the treatment of malaria are derivatives of quinoline and acridine, and 
until recently, there was no alternative chemotherapy. Unfortunately, none of the 
drugs mentioned above is particularly effective against P. falciparum, the most serious 
form of the infection. Recently, a new lead compound, Artemisinin (16), has 
appeared and early prospects are quite promising. 
Artemisinin as Antimalarial Agent 
Artemisinin (Qinghaosu in Chinese) is derived from the plant Qinghao, Artemisia 
annua L. (sweet wormwood or annual wormwood), a weedlike plant growing over 
large parts of China. Qinghao had been used to treat fevers and malaria in China and 
Vietnam for 2000 years. In the Bencao Gangmu (or "Systematic Materia Medica") it 
is stated rather concisely that Qinghao "can cure malaria, fever and cold". It was not 
until 1972 that Chinese scientists isolated the active ingredient in the herb and began 
research that found it to be extremely effective in treating P. falciparum. 
The structure of artemisinin, as well as its absolute configuration was determined by 
X-ray diffraction as 16. 
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The lactone ring has a trans configuration. The most unusual feature of the chemical 
structure is the 1,2,4-trioxane ring which may also be viewed as a bridging peroxide 
group. Artemisinin is the only known 1,2,4-trioxane occuring in nature, although 
compounds with peroxide bridges are common, particularly in marine organisms. 
Derivatives of artemisinin are only a couple of years away from widespread use. 
Artemether (17) is an oil-soluble injectable that is currently being produced in France 
and which was likely to be approved and registered in France and a number of other 
countries in the near future. The ether derivative, arteether (18), is a similar oil-
soluble injectable. Arteether is a better antimalarial agent than artemisinin itself and 
is the form of artemisinin which is also currently under commercial development in 
the Netherlands under World Health Organization (WHO) guidance. Esters (19) are 
generally as effective as artemisinin but the parent acids are much less so, and this 
may be a consequence of their lower solubility in lipids. Carbonates (20) are the least 
effective of this group of compounds. Sodium artesunate (the sodium salt of artesunic 
acid) (21) is only slightly less effective than artemisinin in vitro and has the advantage 
of water solubility and can be administered orally however it is said to be showing 
evidence of toxicity. Other highly effective antimalarial compounds have been 
obtained by replacing the carbonyl group of artemisinin by a substituted amino group. 
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It is almost certain that the crucial structure in artemisinin which gives it its 
antimalarial activity is the peroxide bridge. Research has been done on modifying 
other parts of the molecule and it was found that the modified molecules are still 
active antimalarial agents. Many compounds not obviously related to artemisinin but 
which contain a peroxide group are antimalarial agents in vitro although none is active 
in vivo. This suggests that the remainder of the artemisinin molecule is responsible 
for the delivery of the drug to the infected erythrocyte in a still active form where it 
can excercise its toxicity towards malarial parasites. 
The action of artemisinin on the malarial parasites appears to be completely different 
from that of chloroquine and this may be the reason that artemisinin is effective 
against chloroquine resistant strains of the parasite. Most research suggests that 
artemisinin acts by an oxidative mechanism and that it affects changes in both red 
blood cells and the membranes of the malarial parasites. At a molecular level, it is 
possible that the oxygen-oxygen bond of the peroxide bridge is broken due to an 
electron transfer with the generation of an oxygen-centred radical (Schemel). This 
radical species could be responsible for the destruction of the membranes of the 
malarial parasites. 
• 
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Scheme 1 
Shortcomings of artemisinin and its derivatives as antimalarial agents are low 
solubility in both oil and water. Efficacy by oral administration is poor and 
administration by injection is a problem in countries where medical facilities are 
inadequate. Also, there is a high level of recrudescence in treated patients. Therefore, 
much more work is still waiting to be done in providing the world with a really 
successful new antimalarial drug15• 
Resistance to Antimalarial Agents 
About a decade ago, it was believed that malaria would be successfully eradicated as 
the insecticide DDT was widely used to successfully eliminate the vector mosquito 
and the antimalarial drug chloroquine proved effective and relatively inexpensive. In 
the tropics, chloroquine became a common fixture, although it was sometimes used 
indiscriminately. In the 1950s, one experiment in Cambodia which was supported-by 
the World Health Organization and the U.S. Agency for International Development 
(AID), had table salt laced with chloroquine and distributed as a preventive in the 
Pailin region, one of the most malaria-ridden parts of Indochina. The major 
resurgence of malaria in that region was due to the outbreak of chloroquine resistant 
strains of Plasmodium falciparum. Resistance to chloroquine was first detected in 
1958 in South America and South East Asia. Since then, elsewhere in the world, 
other strains of the parasite have shown resistance to each successive drug that has 
been developed to treat the disease. Resistance was first reported from Africa in 
1979, from both Kenya and Tanzania. Cambodia is beset by a particularly deadly 
23 
strain of the parasite that has proved resistant to all the standard drugs - most likely, as 
experts said, a result of the earlier experiment in which table salt was laced with 
chloroquine. The insecticide DDT, although still used in many places, is also losing 
its effectiveness, as the female Anopheles mosquito, the insects which transmit 
malaria, are showing resistance to it16• 
Today, fewer tools are available to control malaria than 20 years ago. The parasite 
adapts to new drugs faster than they can be developed. The parasite develops 
resistance when it encounters a concentration of a drug that is not potent enough to 
kill it. This happens when patients fail to take the full course of prescribed treatment 
or when drugs are used indiscriminately as prophylactics. Therefore in summary, drug 
resistance results from two factors 14: 
1. The remarkable adaptability of Plasmodium; 
2. The use of antimalarials for prophylaxis, and for inadequate routine treatment of 
un-diagnosed fevers in endemic areas. 
Although there exist other strategies for malaria prevention, control and erradication, 
drugs constitute the most convenient and obvious method for the control of malaria. 
However, up to now there have been only four standard antimalarial drugs available: 
quinine, chloroquine, mefloquine and halofantrine. All have lost some of their 
effectiveness, in some cases as much as 50%. Undoubtedly, there is an urgent need 
for the development of completely new antimalarial drugs and for drugs which may 
potentiate effects of currently used antimalarials or reverse drug resistance. 
The relatively recent discovery of the effective new antimalarial agent artemisinin 
from extracts of Artemisia annua has encouraged the search for other plant-derived 
compounds which may have similar properties as artemisinin. The importance of 
artemisinin and its derivatives is that they are believed to act on the parasite in a 
completely different manner from quinine and its derivatives. The importance of an 
antimalarial with a completely new mode of action is emphasized by the rapid 
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development of multi-drug and cross-resistant strains of Plasmodium falciparum to 
quinine and its derivatives. Natural products research has the ability to produce novel 
compounds with novel modes of action which cannot be achieved by synthetic 
approach which is currently favoured by pharmaceutical companies. 
_ _j 
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1.6. Approaches in the Development of New Antimalarial Drugs 
Two approaches have been undertaken recently in the development of new antimalarial 
drugs. One approach is to modify the existing active drugs in ways which retain the 
antimalarial activity but where the modified drugs are not recognized by the proteins 
involved in resistance. The other approach is to search for novel compounds with 
antimalarial activity from medicinal plants or other natural sources. Examples will be 
illustrated for each approach. 
Modifying of the Existing Drugs 
Chloroquine had always been a mainstream antimalarial drug, however, due to the 
development of resistant parasites, it gradually looses its efficacy. By following the 
approach of modifying drugs, there is interest in this regard in bisquinolines, as the 
bulky bisquinoline structure may be less efficiently extruded by chloroquine resistant 
Plasmodium falciparum. A number of bisquinolines have been examined. A typical 
example is piperaquine (22) which has shown in vitro activity against strains of P. 
f alciparum18 and activity against P. berghei in mice and against P. f alciparum in 
humans19. Bis-( 4-amino-7-chloroquinolines) (23) which have been synthesized 
recently, where Risa series of alkane bridges of varying length, were shown to be very 
effective antimalarial agents with significantly ~ower resistance index than 
chloroquine20• Another series of bisquinolines (24) where the aminoquinoline part of 
chloroquine is retained and the two units are joined by bisamide links from the 
carbocyclic ring have been prepared and some antimalarial activity was shown21 • 
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Searching for Novel compounds with Antimalarial activity 
Two of the mainstay clinically active antimalarial agents, quinine and artemisinin were 
both originally isolated from plants, and some other classes of compound including the 
quassinoids and selected limonoids, have demonstrated activity against Plasmodium 
f alciparum in culture. Recognizing this potential, many researches have investigated 
plants for the treatment of malaria or fevers. A comprehensive review on the progress 
made in the search for antimalarial agents from plants has been published22. Some 
illustrative examples are provided below. 
From Stephania erecta, (+)-2-N-Methyltelobine (25), together with twelve other 
bisbenzylisoquinoline alkaloids were isolated, which inhibited the growth of cultured 
Plasmodium falciparum strains D-6 and W-2 and displayed nonselective cytotoxicity 
27 
with a battery of cultured mammalian cells. However, these bisbenzylisoquinoline 
alkaloids do not appear to be promising clinical candidates23 . 
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The same group of researchers have investigated another plant in the same family, 
Stephania pierrei, after biological evaluation of extracts prepared from the tubers of it 
revealed cytotoxic and antimalarial activity. Two aporphine alkaloids, (-)-asimilobine-
2-0-f3-glucoside (26) and (-)-nordicentrine (27) together with twenty-one isoquinoline 
alkaloids were isolated. 
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However, none of the isolates showed a degree of selectivity comparable to that of 
antimalarial drugs such as chloroquine, quinine and artemisinin24• 
_J 
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Recently, investigation of the two African plants families, the Ancistrocladaceae and 
the Dioncophyllaceae found that they produce a unique class of natural products: the 
naphthylisoquinoline alkaloids such as Dioncopeltine A (28) and Dioncophylline C 
(29). These compounds consist of a naphthalene and an isoquinoline moiety, linked by 
a biaryl axis, which due to the steric demand of the two halves, gives rise to restricted 
rotation and thus to the phenomenon of atropisomerism and axial chirality. Further 
characteristic structural features are the methyl group at C-3 and the oxygen function 
at C-8. 
One of the presently most exciting biological properties of these alkaloids is their 
antimalarial activity. Some Ancistrocladus species are used in traditional medicine for 
the treatment of malaria. Their extracts indeed exhibit high in vitro activities against P. 
falciparum, including chloroquine-resistant strains. Compounds 28 and 29 were found 
to have excellent ICso values (0.021 µg/ml and 0.014 µg/ml respectively)25 . 
Me 
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1. 7. Antimalarial Tests Employed in this Study 
Two antimalarial tests were used in this project for evaluating the activity of various 
extracts and pure compounds. Although the biological details of these two tests are 
beyond the scope of this project, the basic principles are given briefly as follows: 
Parasite Lactate Dehydrogenase Drug Sensitivity Assay 
It has been shown that parasite lactate dehydrogenase (pLDH) activity can be 
distinguished from the host LDH activity using a 3-acetyl pyridine adenine dinucleotide 
analogue (APAD) of nicotinamide adenine dinucleotide (NADH)26• Based on this 
discovery an enzymatic assay was developed for evaluating antimalarial activity27• This 
method of measuring P. f alciparum drug sensitivity is based on measuring the parasites 
survival rate against the various concentrations of drug to which the parasites were 
exposed. Only living parasites produce AP AD and therefore measuring the level of 
AP AD at different drug concentrations is a clear indication of the amount of living 
parasites. 
Parasite LDH can easily be distinguished from host LDH since only parasite LDH 
converts a substrate, nitroblue tetrazolium to a blue formazan salt. The intensity of 
this blue formazon salt can be measured spectrophotometrically and is a direct 
indication of the amount of living parasites. 
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Inhibition of Tritiated Hypoxanthine Uptake Assay 
This assay provides quantitative measurements of the antimalarial activity of 
compounds. It is based on the inhibition of uptake of a radiolabelled nucleic acid 
precursor, tritiated hypoxanthine, by the parasites during the short term culture in 
microtitration plates. The principle of the assay rests on the fact that only living P. 
f alciparnm parasites have the ability to take up the radio labelled tritiated 
hypoxanthine29' 30• 
The effect of a plant extract or compound on the malaria parasites is most conveniently 
described by the ICso value which is the drug concentration that reduces the density of 
a culture of parasites to 50 % of the control parasite density. 
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CHAPTER2 
PASSERINA OBTUSIFOLIA 
2.1. Introduction 
Passerina obtusifolia belongs to the family Thymelaeaceae. The genus Passerina is 
readily distinguishable from other South African Thymelaeaceae by ericoid leaves 
with a groove on the upper side lined with hairs, and small wind-pollinated flowers 
with exerted stamens, dusty pollen and penicillate stigma30• In particular, P. 
obtusifolia is an erect shrub up to 2.5 m tall with symmetrically placed leaves and 
clusters of tiny dark red flowers. It is frequently found in kranses on the Langkloof 
and the coastal dunes. The flowering season for P. obtusifolia is between August to 
October31 • 
P. obtusifolia has been used as a traditional medicine for the treatment of fevers and 
coughs, although there is no reported literature available on the chemical constituents 
-of the plant. Dried plant material of stems and leaves was supplied by the Department 
" 
of Pharmacology, UCT. 
2.2. Results and Discussion 
In order to investigate the antimalarial activity in P. obtusifolia, four extracts were 
prepared: 
1. petroleum ether extract of the stems (POSP); 
2. ethanol extract of the stems (POSE); 
3. petroleilpl ether extract of the leaves (POLP) and 
\ 
4. ethanol extract of the leaves (POLE). 
The results of in vitro tests of activity against P. falciparum on these four extracts are 
"'-, 
summarised in Table l .~ 
Table 1 The ICso values of the four extracts obtained froniP. obtusifo/ia 
::::::::::::::,:Iiiiii:i:::i:i:::::§!t!£Mn,~g::::J::1:1:=:i:l:·=1.J::1,,:l.\,=.=. Extract 
~~-.e.e.e.t-~~~P~O~s=p:--~-----t 
POSE 
POLP 
POLE 
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It is clear that POSP possessed the highest antimalarial activity, .and this fraction was 
therefore subjected to further fractionation on silica gel columns eluting · with 
petroleum ether and EtOAc. Eleven fractions (fractions A to K) were obtained and the 
results of the antimalarial test are summarised in Table 2. 
Table 2 The ICso values of fractions A to K obtained from the extract POSP 
ICso (µg/ml) 
> 100 
> 100 
> 100 
> 100 
> 100 
10- 50 
ICso (µg/ml) 
50 - 100 
50 - 100 
> 100 
10 - 50 
50 - 100 
Fractions F and J were both shown to possess the highest _antimalari~ activity, and 
since fraction J was present in larger quantity, it was subjected to further fractionation 
on silica gel from which two compounds were isolated (compounds JO and 32). 
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2.2.1. Structural Elucidation of Compound 30 
Compound 30 was isolated as a white crystalline compound with melting point 210 -
213°C. Analysis ofHREIMS, various NMR spectra and literature suggested 30 was a 
hydroxylated pentacyclic triterpenoid with the structure shown below. This was one 
of the three related structures encountered in this work, the other two being 32 and 42 
described later. Full details of the structural elucidation of 30 are therefore given 
below to provide a basis for analysis of the other structures. 
OH 
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HREIMS of 30 showed a molecular ion at rn/z = 442.3798, corresponding to the 
molecular formula C30Hso02, which suggested that 30 is a triterpenoid. A 
fragmentation peak appeared at rn/z = 424 (i.e. M+ - H20) indicating that there is at 
least one hydroxy group present in the molecule. Preliminary analysis of the 1H NMR 
spectrum (Appendix, spectrum 1) revealed firstly the presence of 6 methyl groups 
including one three proton singlet at 81.67 ppm, which is typical of a vinylic methyl 
group. Two doublets at 84.57 and 4.67 ppm, indicated the presence of a terminal 
methylene group which was shown on the HMBC spectrum to be long range coupled 
to the vinylic methyl group. Signals in the region 83.30 to 3.80 ppm integrating for 
three protons indicated the presence of oxygenated methine or methylene groups. The 
13C and DEPT spectra (Appendix, spectra 2 and 3) confirmed the presence of the 6 
methyl groups and the terminal olefinic methylene group (8109.64 and 150.50 ppm), 
and indicated the presence of one CHOH (876.22 ppm) and one CH20H group 
(860.55 ppm). The DEPT spectrum also confirmed the presence of, in total, six 
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methine carbons, 12 methylene carbons, six methyl carbons and, by difference, six 
quaternary carbons. This was consistent with the presence of the pentacyclic 
triterpenoid skeleton as shown. 
The complete assignment of an the carbon signals, together with all resolved proton 
signals was possible with the aid of the COSY, HMQC, HMBC and NOESY spectra 
(Appendix, spectra 4, 5, 6 and 7), and with reference to the literature, in particular the 
extensive review of 13C data on triterpenoids by Mahato et. al. 13. The correlations 
observed in the HMBC and NOESY spectra are summarised in Tables 5 and 6 and the 
most significant of these is discussed below. 
As a starting point, the protons in the vicinity of the terminal olefin were readily 
assignable: from the HMQC spectrum, carbons 20, 29 and 30 could be assigned. The 
assignment of H-19 (52.36 ppm) was confirmed by the HMBC and NOESY spectra: 
from the HMBC spectrum, H-19 was shown to be long range coupled to C-20, C-29 
and C-30 and on the NOESY spectrum, H-19 showed a correlation to H-29a. The 
shape of the signal for H-19 in the 1H NMR spectrum appeared to be ddd with J = 
10.83, 10.83 and 5.87 Hz, which was consistent with two large antiperiplanar (H-19 to 
H-18 and H-19 to H-21a) and one smaller synclinal {H-19 to H-21~) coupling. From 
the HMQC spectrum, C-19 could then be assigned to 547.81 ppm. 
From the NOESY spectrum, H-19 showed an NOE to the signal at 53.32 ppm, which 
together with the signal at 53. 79 ppm were shown to be doublets and were associated 
with the same oxygenated carbon at 560.55 ppm as shown in the HMQC spectrum, 
indicating that the primary alcohol was at the carbon position 28 and not 27 (from 
literature, 27-0H and 28-0H are the most commonly occurring in this family of 
structure). 
The HMBC spectrum supported the assignment of the primary alcohol as discussed 
below: in the HMBC spectrum, H-19 was long range coupled to C-20, C-29, C-30 
(which could be readily assigned as discussed above) and the signals at 548. 79 and 
30.45 ppm. The signal at 548. 79 ppm was shown by the HMQC spectrum to correlate 
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with only one proton and confirmed to be a methine carbon by the DEPT spectrum. 
Therefore, the carbon signal at 848.79 ppm was assigned to C-18 as it was the closest 
methine carbon to H-19. Figure 1 shows the sub-structure of rings D and E of the 
molecule. 
{ 
Figure 1 
After assigning C-18, H-18 could be easily assigned by the HMQC spectrum to be at 
81.56 ppm. From the HMBC spectrum, H-18 was shown to be long range coupled to 
the carbon signal at 860.55 ppm, which is the primary alcohol. This again suggested 
that the primary alcohol was at the C-28 position as C-27 is too far from H-18 to 
observe a cross-peak. The assignment of H-18 was also confirmed by the NOESY 
spectrum where H-18 showed a NOESY to the methyl protons at 80.99 ppm, which 
was independently assigned as Me-27 as discussed below. 
The methyl groups were then assigned as follows: firstly, the methyl signal at 80.99 
ppm was the only one that did not show NOESY correlation to any of the other 
methyls, suggesting it was the one at C-27 on the a-face of the molecule. The geminal 
dimethyl groups, typically at C-4 in triterpenoids, were recognized from the common 
HMBC correlations observed for signals at 80.81 and 0.93 ppm, suggesting these were 
Me-23 and Me-24. Of these two methyl signals, only the signal at 80.81 ppm showed 
NOESY connectivity to the methyl signal at 80.83 ppm, suggesting that these were 
Me-24 (the J3-methyl group at C-4) and Me-25 respectively, and this left the signal at 
80.93 ppm to be assigned as Me-23. Me-25 was in tum correlated to the signal at 
81.01 ppm and this was therefore assigned as Me-26. 
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These NOESY connectivities are illustrated in Figure 2 below. 
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Figure 2 
The secondary alcohol was assigned as follows: the proton signal at 03.37 ppm (which 
was shown to be associated with the carbon signal at 076.22 ppm on the HMQC 
spectrum) showed NOESY correlations to both Me-23 and Me-24, suggesting it was 
in a gauche relationship to both methyl groups: the proton signal at 03.37 ppm was 
therefore concluded to be H-3~. The multiplicity and coupling constant of the signal 
supported the assignment as it appeared to be a triplet with J = 2.85 Hz, typical of two 
overlapping vicinal synclinal couplings to adjacent protons (H-3~ to H-2a and H-3~ to 
H-2~). 
After assigning C-3, C-4, C-18, C-19, C-20, C-28, C-29 and all the methyl groups, the 
HMQC, HMBC and NOESY spectra were used for the assignment of the methine 
carbons: C-5 could be identified from the connectivities shown in the HMBC 
spectrum for Me-23 and Me-24 (C-3, C-4 and C-5); C-13 could be identified from the 
connectivities shown for Me-27 (C-8, C-13, C-14 and C-15), which also led to the 
identification of the methylene carbon C-15; C-9 could be identified from the 
connectivities observed for Me-25 (C-1, C-5, C-9 and C-10), which also led to the 
identification of the methylene carbon C-1 and the quaternary carbon C-10. C-2 was 
identified from the connectivities shown for H-1 (C-2 and C-3) and H-3~ (C-2 and C-
S). The NOESY spectrum confirmed these assignments as Me-26 showed a 
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correlation to H-13, Me-27 showed a correlation to H-9, H-5 was shown to be 
correlated to H-la, and Me-25 and Me-24 were both shown to be correlated to H-2p. 
The rest of the carbons were assigned using a combination of the various 2D NMR 
spectra and the literature data. The complete assignments of the 1H and 13C NMR 
spectra are shown in Tables 3 and 4. 
30, 32 and 42 were found to possess features of the triterpenoid lupeol (31). 
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Compound 30 was thus concluded to be the known compound epi-betulin32 (betulin 
has a P-OH at C-3)33'34• Close examination of the literature data for epi-betulin 
revealed the incomplete assignments of the 1H spectrum and the absence of published 
13C NMR data. 
Table 3 · 1H NMR spectrum assignment of 30 
o(ppm), multiplicity* 
and J(Hz) 
1.22, 1.37 
1.51, 1.92 
3.37, dd, 
2.85 Hz 
1.18 
1.38, 1.39 
1.43, 1.84 
1.40 
1.18, 1.42 
1.04, 1.61 
1.64 
1.04, 1.69 
1.20, 1.91 
J = 2.85, 
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o(ppm), multiplicity* 
and J(Hz) 
1.39, 1.95 
4.67, d, I= 1.60 Hz 
1.67, s 
* indicates multiplets were assumed wherever multiplicities were not stated 
B(ppm) 
33.26 
25.40 
76.22 
37.53 
49.01 
18.26 
34.12 
41.13 
50.19 
37.30 
20.70 
25.22 
37.30 
42.80 
27.01 
Table 5 HMBC experiment results of JO 
C-13, C-19, C-20, C-28 
. C-18, C-20, C-21, C-29, C-30 
C-17, C-18, C-19, C-20 
39 
B(ppm) 
29.20 
47.84 
48.79 
47.81 
.150.50 
30.45 
33.98 
28.22 
22.12 
15.90 
15.99 
14.86 
60.55 
109.64 
19.75 
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Table 6 lists all the NOESY's observed for 30. By careful examination of the NOESY 
spectrum and molecular models, it was possible to distinguish the two diastereotopic 
protons for all the eleven methylene groups present in the molecule (see Table 6). In 
particular NOESY' s observed for the two diastereotopic protons at C-28 suggested 
that this methylene group may not experience free rotation. One of the signals (at 
83.79 ppm) showed NOESY's to H-13, H-15P, Me-26 and its geminal partner, 
whereas the other (at 83.32 ppm) showed NOESY's to H-19, H-21P and its geminal 
partner. These results suggested that the signal at 83. 79 ppm was due to H-28R and 
that H-28s was at 83.32 ppm as shown in Figure 3. Also, the two terminal methylene 
protons at C-29 could be distinguished as H-29a showed NOESY's to H-29b, H-12P 
and H-19, whereas H-29b showed NOESY's to H-29a and Me-30 only. This 
suggested that Me-30 was most likely to be anti to H-19. Figure 3 shows the sub-
structure of rings D and E of 30 with the various NOESY' s observed indicated. 
Figure 3 
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Table 6 NOESY experiment results of 30 
o(ppm) NOESY' s observed , 
l.22 H-Ia, H-5 
1.37 H-Hx 
l.51 · H-2a 
L92 H-2a, H-1a, Me-24, Me-25 
3.37 H-2a, H-2'3, Me-23, Me-24 
. 1.18 H-la H-9 Me-23 
, ' 
1.38 H-6a, Me-23 
1.39 . Me-24, Me-25,· Me-26 
1.84 H-lSci, Me-27 
1.43 · H·l5a 
1.40 . 
· H-5, H-12a, Me-27 
1.42 a-11a. H-12a. 
1.18 H-1 la, H-13, Me-25, Me-26 
1.04 H-12a, Me-27 
1.61 H-12a H-13 H-29a 
' ' 
1.64 H-11a. H-12'3, H-19, Me-26 
1.04 H-15a, H-1a 
1.69 H-15a, Me-26 
1.20 H-16a, H-18,.H-22a, Me-27 
1.91 H-I6a, H-22a 
1.56 Me-27 
2.36 H-13, H-21'3, H-288, H-29a 
1.39 H-21'3, Me-30 
1.95 H-2la H-19 H-28s H-22'3 
, ' ' 
1.02 H-22'3, H-18, H-2la 
1.37 H-22a, H-21'3 
0.93 H-6a, Me-24 
0.81 H-2'3 Me-23 Me-25 
' , 
0.83 . H-2'3, H-6'3, Me-24, Me-26 
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Table 6 NOESY experiment results of30{cont.) 
B(ppm) NOESY' s observed 
1.01 H-6~, H-13, H-15~, Me-25 
0.99 H-9, H-16a 
3.79 H-13, H-15~, H-28s, Me-26 
3.32 H-19, H-21~, H-28R 
4.67 H-12~, H-19, H-29b 
4.57 H-29a, Me-30 
1.67 H-12a, H-29b 
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2.2.2 Structural Elucidation of Compound 32 
Compound 32 was isolated from fraction J as a white crystalline compound with m.p. 
215 - 217°C. Analysis results of HREIMS, various 1 D and 2D NMR spectra and 
literature suggested that 32 was a hydroxylated pentacyclic triterpenoid with the 
structure shown. 32 is one of the three triterpenoids encountered in this study, the 
other two being 30 and 42. 
Jl ..... H 
OH 
32 
HREIMS showed a molecular ion at m/z = 458.3756, which corresponded to the 
molecular formula C30Hso03 (cal. 458.3760), this suggested that 32 was a triterpenoid. 
The fragmentation peaks at m/z = 440 (i.e. M+ - H20) and 422 (M+ - H20 - H20) 
indicated that there were at least two hydroxy groups present in the molecule. By 
comparing the spectroscopic data of 32 with 30, many similarities were observed, 
such as the number and chemical shifts of the methyl groups, the presence of a 
terminal olefinic methylene group and the presence of hydroxyl groups. These led to 
the conclusion that 32 also possessed a basic lupeol structure (31). A full assignment 
of the 1H and 13C NMR spectra was carried out in a similar way to that for 30 reported 
above, and only the significant features of this analysis are reported here. 
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Examination of the 1H, 13C NMR and the HMQC spectra (Appendix, spectra 8, 9 and 
12) of 32 revealed that there were two secondary hydroxyl groups (13Cs 76.17 and 
79.22 ppm) and one primary alcohol {13Cs 61.18 ppm), confirming that 32 is a triol. 
The presence of a 3a-hydroxy group was deduced as for 30 from the 1H, HMBC. and 
NOESY data which confirmed a 3'3-H at 03.37 ppm. The presence of a 28-0H was 
· also confirmed by a similar argument to that for 30. The extra hydroxy group was 
located at C-16 on the basis of literature data and the HMB.C and NOESY spectra 
(Appendix, spectra 13 and 14), and this and its '3-orientation was deduced as follows. 
The proton signal at 03.81 ppm in the 1H NMR spectrum appeared to be dd with J = 
11. 0 and 4. 0 Hz, which implied an axial proton since this would give one large vicinal 
antiperiplanar coupling and one smaller synclinal coupling. In the HMBC spectrum, 
the signal at 03.81 ppm showed long range coupling to C-28; however, there was no 
NOESY correlation between the signal at 03.81 ppm and any of the protons on C-28, 
which suggested that the proton signal at 03.81 ppm was on the a-face of the 
molecule. Of the two possible positions, I Sa and l 6a in ring D, the l 6a would be 
axially oriented and this suggested that the hydroxy group was therefore attatched at 
C-16 in a '3-orientation. This assignment was confirmed by the observation ofNOESY 
correlations between H-16a and Me-27 (methyl groups were assigned by the same 
strategy as discussed for 30). The sub-structure for rings D and E of 32 is shown in 
Figure 4. 
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In the NOESY spectrum, H-16cx. showed further NOESY's to H-15cx., H-18 and H-
22cx.. Figure 5 shows the NOESY's observed for H-16cx.. 
Figure 5 
It is interesting to notice that H-18 and H-19 both showed NOESY's to H-29a and 
Me-30. This implied a free rotation around the C-19 - C-20 bond. Figure 6 illustrates 
the two alternative orientations for the isopropenyl group with the various NOESY' s 
observed indicated. 
Figure 6 
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Complete assignment of the 1H and 13C NMR spectra was possible by the aid of the 
HMQC, HMBC and NOESY spectra. These assignments are shown in Tables 7 and 8, 
Tables 9 and 10 show the results of the HMBC and NOESY experiments, and it is 
interesting to notice the almost identical 13C chemical shifts of 30 and 32 for C-1 to C-
13 and C-18 to C-30. 
Thus, 32 was concluded to be (20)29-lupene-3a, l 6f3,28-triol. This is the first known 
occurence of this compound, although the epimer, (20)29-lupene-3 f3, l 6f3,28-triol has 
been reported before35' 36 . 
. Table 7 1H NMR spectrum assignment of 32 
B(ppm}, multiplicity# ' 
and J(Hz} 
1.22, 1.37 
1.53, 1.92 
3.37, dd+ 
1.20 
<1.41 >* 
< 1.46 >* 
1.37 
1.16, 1.45 
0.97, 1.61 
1.54 
1.42, 1.86 
3.81, dd, J = 11.00, 
4.00Hz 
*indicates mean values 
B(ppm}, multiplicity# 
"''"'''""'''''''''::::::::=:::::::1 and J (Hz) 
1.67, s 
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+indicates multiplicity was deduced from the shape of cross-peaks in the HM:QC 
spectrum and spin coupling considerations as there were peak overlappings in that 
region and therefore J values were not available 
#indicates multiplets were assumed wherever mltiplicities were not stated 
Table 8 13C NMR spectrum assignment of 32 
o(ppm) 
33.30 
25.38 
76.17 
. 37.53 
49.02 
18.24 
34.11 
41.20 
49.70. 
37.25 
20.60 
24.93 
36.59. 
44.74 
37.53 
* indicates a~signmen~s could be interchangeable 
o(ppm) 
79.22 
51.42 
48.01 
47.61 
149.62 
29.91 
32.09 
28.22 
22.09 
16.01 * 
16.10* 
15.90* 
61.18 
110.01 . 
19.26 
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Table 9 HMBC experiment results of 32 
::::::::::::::::::::::::::::::::1 
C-1 C-5 , . 
C-4, C-24 
C-8 
Connectivities observed 
C-13, C-14, C-16, C-17, C-27 
C-14, C-16, C-27 
C-28 
C-13, C-19; C-28 
C-13, C-17, C-18, C-21, C-28 
C-19 
C-4, C-5, C-24 
C-:J C-4 C-S c .. 23 , ' , 
C-1, C-3, C-9, C-10 
C-7, C-8, C-9, C-14 
C-8, C-13, C-14, C-15 
C-16, C-22 
C-19, C-30 
::::::;::::}:,'::::;:::::{'::;::::::1 C-19 C-20 C-29 
.. ' 
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Table I 0 NOESY experiment results of 32 
o(ppm) 
1.22 
1.37 
1.53 
1.92 
3.37 
1.20 
1.42 
1.40 
1.47 
1.44 
1.37 
1.45 
1.16 
0.97 
1.61 
1.54 
1.42 
1.86 
3.81 
1.51 
2.43 
1.47 
2.06 
1.16 
2.41 
0.93 
0.82 
0.83 
1.05 
NOESY's observed 
H-113, H-9 
· H-Ia 
H-213 
H-2~ H-3n Me-24 Me-25 u.., ..,, ' 
H-213, Me-23, Me-24 
H-9, Me-23 
Me-23 
. 
Me-23, Me-24, Me-25 
H-5, H-9, Me-27 
H-.5, H-7a, Me-27 
H-1113, H-12a 
. H-I Ia, Me-25, Me-26 
H-1213 
H-I2a, H-29a 
H-19, Me-26 
H-1513 
H-l 5a H-28R Me-26 · 
, ' 
H-15a, H-18, H-22a, Me-27 
H-16a, H-29a, Me-27, Me-30 
H-2lf3, H-288, H-29a, Me-30 
H-2113, Me-JO 
H-19, H-21a, H-2213, H..:28s 
H-l6a, H-18, H-2la, H-2213 
H-2lf3, H-22a 
H-313, H-5, Me-24 
H-2(.l H-Jf.l H-61'.l Me-23 Me-25 ...,, ...,, , ...,, ' 
H-2f.l H-6A Me-24 Me-26 .,, ...,, , 
H-1513, H-28R, Me-25 
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Table 10 NOESY experiment results of32 (cont.) 
(ppm) NOESY's observed 
1.00 H-7a, H-9, H-16a, H-18 
4.15 H-13, H-15~, H-28s, Me-26 
3.37 H-19, H-21~, H-28R 
4.68 H-18, H-19, H-29b 
4.59 H-29a, Me-30 
· 1.67 H-18, H-21a, H-29b 
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2.3. Conclusion 
Passerino obtusif olia was identified as a potential antimalarial plant on the basis of its 
traditional· usage. Bio-assay-guided fractionation was employed for the isolation of 
possible antimalarial principle(s). Two triterpenoids (compounds 30 and 32) were 
isolated and identified from the active fraction of stems extract of P. obtusifolia. The 
structures of 30 and 32 were deduced from their various ID and 2D NMR spectra and 
literature. The 1H and 13C NMR spectra of 30 and 32 were fully assigned by the aid of 
the COSY; HMQC, HMBC and NOESY spectra. Antimalarial tests showed 30 and 
32 to be inactive against malarial parasite Plasmodium falciparum (the ICso values for 
30 and 32 were >JOO and 40 µg/ml respectively). 
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CHAPTER3 
TETRADENIA RIPARIA 
3.1. Introduction 
Tetradenia riparia is a deciduous shrub which grows in the shade of other trees and 
shrubs in dry woods and rocky hillsides. It is easy to propagate when it serves as a 
garden plant although it cannot withstand frost. The plant loses its leaves in late 
autumn and flowers bloom soon afterwards37. Figures 7 and 8 show the male and 
female flowers of Tetradenia riparia38• Tetradenia riparia is frequently grown in the 
Eastern Transvaal and Natal, also to some extent in the Northern Transvaal. It also 
grows in areas of Zimbabwe, Namibia, Botswana and Swaziland. Several other 
species grow elsewhere in Africa39• 
In the book " The Medicinal and Poisonous plants of Southern and Eastern Africa" by 
Watt and Breyer-Brandwijk, it is stated that Tetradenia riparia (also known as lboza 
riparia) possesses many medicinal properties including effectiveness against 
malaria40. Watt and Breyer-Brandwijk describe an infusion of the leaf to be effective 
against malaria: "the patient taking one dose only at bed-time and is apparently well 
the next day". 
In southern Africa, the Zulu administer an infusion of the leaf for coughs and 
respiratory troubles. Sometimes it is taken as an emetic to clear the respiratory 
passages of phlegm. The Lala use an infusion of the young shoots for similar 
purposes40 . Githens (in 1949) described how in South Africa the leaf is used as a 
remedy for diarrhoea and for heamoptysis and is said to contain a volatile oil41 . 
Further ethnomedical information and information on the biological activities for 
extracts of Tetradenia riparia has been documented since the first description of the 
plants and its uses by Watt and Beyer-Brandwijk back in 1939. 
j 
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Figure 7 Male flowers of Tetradenia riparia 
Figure 8 Female flowers of Tetradenia riparia 
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Much of the research on Tetradenia riparia has been done by van Puyvelde et. al. in 
Rwanda, where it is known under the name Umuravumba. This species is cultivated 
around almost every house as a remedy against a wide range of illnesses including 
malaria, diarrhoea and several kinds of fevers and aches 42• 43 • 
In systematic studies on biologically active substances from medicinal plants of 
Rwanda, significant chemotherapeutic activity was found in the methanolic extract of 
Tetradenia riparia leaves. Numerous novel compounds have been isolated and 
identified in Tetradenia riparia over the years as well as compounds found in other 
plants. Some examples are given here: umuravumbolide· (33), is an a.-pyrone isolated 
in 0.13 % yield from leaf material of T. riparia, deacetylumuravumbolide (34) was 
isolated in 0.11 % yield and deacetylboronolide (35) was isolated in 0.06 % yield44• 
The search for minor constituents of T. riparia resulted in the isolation and structural 
elucidation of another a-pyrone, l ',2' -dideacetylboronolide (36). Three sterols were 
also isolated: sitosterol (37), stigmasterol (38) and campesterol (39)45• A diterpenoid, 
8(14),15-sandaracopimaradiene-7a.,18-diol (40), was isolated from the leaves of T. 
riparia46 and shown to exhibit significant antimicrobial activity against several 
bacteria and fungi47• 
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Certain references have documented antimalarial activity in Tetradenia riparia. In 
1988, Hakizamungu et. al. performed antimalarial assays on the crude extracts of the 
leaves of Tetradenia riparia and found positive antimalarial activity48• Chagnon et. al. 
in 1984 also documented antimalarial activity in Tetradenia riparia49. However, in 
spite of these positive results, a detailed examination of the plant extracts and the 
isolation of possible antimalarial principle(s) had not been pursued until recently. 
In a preliminary study initiated in the Department of Pharmacology UCT in 1994so, the 
dried plant material of Tetradenia riparia was divided into stems, leaves and flowers. 
Petroleum ether and methanol extracts were prepared for each of these plant parts. 
Antimalarial tests revealed that the petroleum ether extract of the leaves possessed the 
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highest activity. This extract was then subjected to fractionation by dry column flash 
chromatography. From this 29 fractions (fractions A to Zc) were produced and the 
results of antimalarial tests showed that fractions H and I were the fractions with the 
highest activity and were both shown by TLC to contain the same compound. . This 
compound was identified as 7a-hydroxyroyleanone (4l)s1 by MS, IR and NMR 
spectroscopy. It was found to have an ICso value of 6.9 µg/ml against P. falciparum 
in vitro and showed cytotoxicity with ICso values against WHCOI and NIH-3T3-MDR 
1.41and1.51 µg/ml respectively. The other active fractions U and V (ICsovalues 12.7 
and 14.6 µg/ml respectively) were not examined further in the preliminary study and 
were therefore included in this study in order to complete the analysis of the T. riparia 
extracts. Four compounds were isolated from these two fractions (compounds 42, 44, 
45 and 51), and the structural elucidation of these compounds will be presented in this 
thesis. In addition, a preliminary investigation of the Diets-Alder reactivity of 41 was 
carried out with a view to preparing analogues for structure-activity studies. 
17 
41 
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3.2 Results and Discussion 
3.2.1. Structural Elucidation of Compound 42 
Compound 42 was isolated from fraction U as a minor constituent. 42 is an off-white 
crystalline compound with m.p. 275 - 278°C. Results ofHRETh1S, various ID and 20 
NMR spectra of 42 and literature data, suggested that 42 is the known compound 
betulinic acid with the structure shown below. It is one of the three triterpenoids 
isolated in this study, the other two being 30 and 32. Full details of the structural 
elucidation of 30 have been given, therefore only significant differences will be 
discussed for this compound. 
HO 
29 
30--l! H 
H 
42 
', 
' 
OH 
HRETh1S showed a molecular ion at m/z = 456.3587, which corresponds to the 
molecular formula C30Jiis03 indicating that 42 is a triterpenoid. The 1H NMR 
spectrum (Appendix, spectrum 15) of 42 showed a three proton singlet at ol.68 ppm, 
which is typical of a vinylic methyl group. Two singlets at 84. 60 and 4. 73 ppm were 
attributed to the terminal methylene protons of an isopropenyl group. 
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By comparing the spectroscopic data of 42 with literature, it was found that 42 was the 
known compound betulinic acid which is the C28-COOH product oflupeol (31). 
A P-OH at C-3 was evident from the dd signal for H-3a at o3 .17 ppm (J = 11.26, 5. 04 
Hz) in the 1H NMR spectrum, typical of a vicinal antiperiplanar and a vicinal synclinal 
coupling to adjacent protons. However, on close examination of the HMQC and 
HMBC spectra (Appendix, spectra 18 and 19) of 42, some revisions were made on the 
reported literature data 13. 
In particular, the assignments of C-18 and C-19 were found to be reversed on the basis 
of the following arguments: 
In the literature, C-18 and C-19 were assigned to 046.8 and 49.2 ppm respectively. If 
these assignments are correct, the HMQC spectrum could identify H-18 and H-19 at 
02.98 and 1.59 ppm respectively. However, H-19 is expected to be further downfield 
than H-18 as it is an allylic proton. Also, in the 1H NMR spectrum, the multiplicity of 
the signal at 02.98 ppm appeared to be a ddd with J = 10.73, 10.73 and 4.40 Hz, this 
coupling pattern is consistent with two vicinal antiperiplanar (H-19 to H-18 and H-19 
to H-21a) and one vicinal synclinal coupling (H-19 to H-21P) to adjacent protons 
which is typical ofH-19 in the lupeol structure (see related compounds 30 and 32). 
In the HMQC spectrum, the shape of the cross-peakfor the proton signal at ol.59 
ppm and carbon signal at 049.31 ppm appeared to be a triplet, which is consistent with 
an overlapping dd with large coupling, i.e. two vicinal antiperiplanar couplings ( H-18 
to H-13 and H-18 to H-19) to adjacent protons. 
The assignment of C-13 was confirmed by the HMBC spectrum. From the HMBC 
spectrum, Me-27 (o0.97 ppm) showed long range couplings to carbon signals at 
040.73, 38.39, 42.47 and 29.71 ppm. The carbon signals at 040.73 and 42.47 ppm 
were found to be quaternary carbons from the HMQC spectrum and the carbon signal 
at 029.71 ppm was found to be a methylene carbon, whereas the carbon signal at 
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838.39 ppm was found to be a methine carbon. This led the carbon signal at 838.39 
ppm to be assigned to C-13 as it was the closest methine carbon to Me-27. From the 
HMQC spectrum, H-13 could be found to be at 82.20 ppm which was a ddd with J = 
12.10, 12.10 and 3.06 Hz consistent with two vicinal antiperiplanar (H-13 to H-12a 
and H-13 to H-18) and one vicinal synclinal coupling to the adjacent protons. The 
COSY spectrum (Appendix, spectrum 17) gave another indication for the assignment 
ofH-18 as the signal at 82.20 ppm (H-13) showed a correlation to the signal at 81.59 
ppm (H-18), which correlated to the carbon signal at 849.31 ppm in the HMQC 
spectrum. 
The HMBC spectrum supported the revised assignments for C-18 and C-19 as the 
proton at 81.59 (H-18) showed long range couplings to C-13, C-17, C-19, C-20 and 
C-28. 
Figure 9 shows the sub-structure of rings D and E for 42. 
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Similarly, the assignments of C-15 and C-21 were found to be reversed in the literature 
as discussed below. 
In the HMBC spectrum, Me-27 (80.97 ppm) showed long range coupling to the 
carbon signals at 840.73, 38.39 (C-13), 42.47 and 29.71 ppm. The carbon signal at 
829.71 ppm appeared to be a methylene carbon from the HMQC spectrum, which was 
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most likely to be C-15 rather than the literature assignment, C-21, as a seven bond 
correlation would be required in the latter case. 
C-16 was assigned to 832.15 ppm on the basis of the literature data. From the HMQC 
spectrum, the H-16 protons could be assigned to 81.44 and 2.26 ppm. In the COSY 
spectrum, the proton signal at 82.26 ppm showed cross-peaks with the protons at 
81.44, 1.52 and 1.19 ppm. The latter two proton signals were found to be associated 
with the carbon signal at 829.71 ppm in the HMQC spectrum. Therefore C-15 was 
reassigned to 829. 71 ppm. 
C-22 was assigned on the basis of the literature data to 837.01 ppm. From the HMQC 
spectrum, the H-22 protons could be found to be at 81.46 and 1.96 ppm. In the 
COSY spectrum, the proton signal at 81.96 ppm showed correlations to the proton 
signals at 81.46, 1.98 and 1.41 ppm. The latter two protons were found to be 
associated with the carbon signal at 830.56 ppm in the HMQC spectrum. Therefore, 
C-21 was reassigned to 830.56 ppm. The down field signals of the H-21 and H-22 
protons (81.98 and 1.96 ppm respectively) could be assigned as H-21J3 and H-22J3 on 
the basis of the carboxylic acid at C-28 causing a deshielding effect on the 
neighbouring protons. 
The only direct evidence from the NMR spectra recorded to confirm the location of 
the carboxyl group at C-28 was the long range coupling of H-18 to the carboxyl 
carbon shown by the HMBC spectrum. 
The full and revised assignments of 1H and 13C NMR spectra are shown in Table 11 
and 12 respectively. The literature data for 13C NMR chemical shifts of betulinic acid 
was listed for comparison. Table 13 lists the results observed for HMBC experiment. 
Recent investigations have revealed interesting bioactivities of betulinic acid. For 
example, it has been shown to have melanoma specific cytotoxicity in vivo. As a 
result, the compound is undergoing preclinical evaluation for the treatment or 
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prevention of malignant melanoma. · Betulinic acid has also been found to have 
promising anti-HIV activity, whereby the. compound inhibits HIV replication52.53 • 
Table 11 1H NMR spectrum assignment of 42 
o(ppm), multiplicity# 
and J(Hz) 
5.04 Hz 
12.10, 3.06 Hz 
1.19*, 1.52* 
1.44*, 2.26 
* indicates mean values 
o(ppm), multiplicity# 
and J(Hz) 
J = 10.73, 
10.73, 4.40 Hz 
1.41 *, 1.98 
1.46, 1.96 
1.68, s 
# indicates multiplets were assumed wherever multiplicities were not stated 
• I 
Table 12 13C NMR spectrum assignment of 42 (in ppm) and literature data 
42 
38.75 
27.41 
78.97 
38.87 
55.39 
18.31 
34.37 
40.73 
50.57 
37.23 
20.88 
25.54 
38.39 
42.47 
29.71 
Literature 
data 
J8.7 
27.4 
78.9 
38.8 
55.3 
18.3 
34.3 
40.7 
50.5 
37.2 
20.8 
25.5 
38.4 
42.4 
30.5 
42 
::,.:::.,:=::::::,::1~:~.~::::.::;:: .. 111:.;1:11: 3 2. 15 
1 .. 1:11 ... :1.-.1::::2~:~:2.:·::,=:-::::i::::·=::; 56.22 
•.··-:·:·:·:·: ::···.·:-.-:• ... •.·,· .. 
49.31 
46.87 
150.38 
30.56 
37.01 
27.99 
15.34 
16.04 
16.13 
14.71 
179.80 
109.69 
19.39 
Literature 
data 
32.1 
56.3 
46.8 
49.2 
150.3 
29.7 
37.0 
27.9 
15.3 
16.0 
16.1 
14.7 
180.5 
109.6 
19.4 
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Table 13 HMBC experiment results of 42 
C-25 
C-25 
C-26 
Connectivities observed 
C-13 C-17 C-19 C-20 C-28 
' ' ' ' 
C-19 
C-18 
C-3, C4, C-5, C-24 
C-3 C-4 C-5 C-23 
• • • 
C-1, C-5, C-9, C-10 
C-7 C-8 C-9 ··C-14 
• • • 
C-8, C-13, C-14, C-15 
C-19, C-30 
C-19, C-20, C-29 
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3.2.2. Structural Elucidation of Compound 44 
Compound 44 was isolated from both fractions U and V as a yellow crystalline 
compound with m.p. 186 - 188°C. The MS of 44 showed a molecular ion at m/z = 
328. The 1H NMR spectrum of 44 (Appendix, spectrum 20) appeared to be very 
simple: 3 singlet methoxy methyl groups were observed at 83.88, 3.91 and 3.96 ppm, 
6 aromatic protons in the region 86.50 - 7.90 ppm including. an AA'BB' system at 
87.00 and 7.83 ppm (J = 9.00 Hz) and 2 singlets at 86.53 and 6.57 ppm. The 13C 
NMR spectrum of 44 (Appendix, spectrum 21) showed 18 peaks including two 
signals with high intensities, suggesting overlapping of the carbon resonances in each. 
Together, the MS and 1H NMR data indicated a molecular formula C18H160 5• The 
UV spectrum of 44 displayed Amax 216 nm, typical of a flavonoid. 
From the 1 H, 13C, UV and the bright yellow colour of 44, it was suspected to be a 
flavone. 
From the literature, a compound called cirsimaritin (43) which was isolated previously 
from Drymis Winteri54 was found to be closely related to 44. 
Meo 
Meo 
43 
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Close examination showed that 44 was the known compound salvigenin55 (5-
Hydroxy-4' ,6, 7-trimethoxyflavone) on the following arguments: 
The aromatic AA'BB' system at 87.83 and 7.00 ppm, both have J = 9.00 Hz, were 
each integrated for two protons and shown to be correlated to each other in the COSY 
spectrum (Appendix, spectrum 22), suggesting they were two chemically equivalent 
pairs of protons which could be assigned to H-2' 16' and H-3' 15'. From the NOESY 
spectrum (Appendix, spectrum 24), the signal at 87.00 ppm showed a correlation to 
the methoxy signal at 83.88 ppm, suggesting the position of this methoxy group was at 
C-4' and the proton signal at 87.00 ppm was assigned H-3'/5'. This left the proton 
signal at 87.83 ppm to be assigned to H-2'/6'. 
The singlets at 86.53 and 6.57 ppm showed no correlation to each other nor to any of 
the other proton signals in the COSY spectrum. The very deshielded -OH singlet at 
812.76 ppm suggested strong hydrogen bonding to the C-4 carbonyl group, thus 
placing the -OH at C-5. On the NOESY spectrum, the proton signal at 86.57 ppm 
showed a correlation to the proton signal at 87.83 ppm which was assigned H-2'/6. 
Therefore the proton signal at 86.57 ppm was assigned H-3 and this left the proton 
signal at 86.53 ppm to be assigned H-8. Methoxyls with at least one hydrogen in the 
ortho position resonate at 855 ppm while those without any ortho proton neighbours 
resonate at 860 ppm. Hence, from the HETCOR spectrum (Appendix, spectrum 23) 
the methoxyl signal at 83.91 ppm (with carbon signal at 859.90 ppm) was assigned 6-
0Me while the one at 83.96 ppm (with carbon signal at 856.30 ppm) was assigned as 
7-0Me. 
Meo 
MeO 
44 
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Table 14 and 15 show the 1H and 13C NMR spectra assignment of 44. The 13C NMR 
spectrwn assignments were based on those reported for cirsimaritin56• 
Table 14 1H NMR spectrum assignment of 44 
Proton o(ppm), Proton,· o(ppm), 
. 
multiplicity and . . ' .• multiplicity and " 
J(Hz) J(Hz) 
H-3 6.57, s 4'•0M~ •.. 3.88, s 
. ' 
H-8 6.53, s 6-0Me . : 3.91, s .,. 
H-2'/6' 7.83, d, J = 9.00 Hz 7-0Me ; 3.96, s 
., 
H-3'/5' 7.00, d, J = 9.00 Hz 5-0H· .. 12.76,s 
..,, 
Table 15 l3C NMR spectrum assignment of 44 
·Carbon o(ppm) Carbon o(ppm) 
C-2 . 164.00 C-8a 153.00 
C".'3 104.14 C-1' 123.57 
C-4 182.66 C-2'/6' 128.00 
C•4a 
,. 
106.14 C-:3'/5' 114.51 
. 
C-5 153.22 
" 
C-4' 162.60 
. C-6 132.63 OMe-4' 55.54 
C-7 158.71 OMe-6 59.90 
C-8 99.55 OMe-7 56.30 
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3.2.3. Structural Educidation of Compound 45 
Compound 45 was isolated from fraction Vas a white crystalline compound with m.p. 
147 - 150°C. By comparing the spectroscopic data of 45 to that of those compounds 
which had been isolated previously from Tetradenia riparia, it was concluded that 45 
is the known compound Ibozol57• Details of the structural elucidation is given below. 
OH 16 
.... lit;, 
l .... ~17 
45 
MS showed a molecular ion at m/z = 306. The 1H NMR spectrum (Appendix, 
spectrum 25) revealed the presence of 5 methyl groups including three singlets (80.86, 
0.88 and 1.05 ppm) and two 3-proton doublets at 80.91 and 0.93 ppm with J = 1.29 
and 1.39 Hz respectively, indicating the presence of an isopropyl group. A carbinol 
methine signal at 84.00 ppm accounted for a secondary hydroxyl group. The Be 
NMR spectrum (Appendix, spectrum 26) confirmed the presence of the secondary 
hydroxyl group as a signal at 872.18 ppm was observed. The other signal at 872.11 
ppm suggested the presence of a tertiary hydroxyl group. In addition, two signals at 
126.76 and 141.76 ppm indicated the presence of a double bond. However, from the 
1
H NMR spectrum, there was no vinyl proton observed and therefore the double bond 
was tetrasubstituted. In the region 81.00 - 2.50 ppm, there were many overlapping CH 
and CH2 signals. Twenty carbon signals were detected in the Be spectrum which 
suggested that 45 is a diterpenoid, and together with MS and 1H NMR data, a 
molecular formula of C20H3402 was deduced. From these results an abietane skeleton 
46 was inferred. The structure of this compound was deduced as follows: 
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17 
46 
The geminal dimethyl groups at C-4 were recognized from the common HMBC 
correlations observed (see Appendix, spectrum 28) for methyl signals at o0.86 and 
0.88 ppm, and these two signals were therefore assigned as Me-18 and Me-19. Me-18 
and Me-19 were shown on the HMBC spectrum to be correlated to the carbon signals 
at 041.39, 33.02 and 49.63 ppm, which were found to be a methylene carbon, a 
quaternary carbon and a methine carbon respectively on the HMQC spectrum 
(Appendix, spectrum 27). These three carbon signals were assigned to C-3, C-4 and 
C-5 respectively. The other methyl singlet at ol.05 ppm could then be assigned to Me-
20. From the HMBC spectrum, Me-20 was shown to be correlated to the signals at 
037.05 (a methylene carbon), 141.76 (a quaternary carbon), 38.40 (a quaternary 
carbon) and C-5, and therefore the double bond could be placed at C-8 and C-9, which 
were assigned at 0126.76 and 141.76 ppm respectively. Also, C-1 and C-10 could be 
assigned at o3t05 and 38.40" ppm respectively. 
H-5 showed long-range coupling to C-1, C-4, C-10 and the carbon signals at 030.06 (a 
methylene carbon) and 72.18 ppm (the carbinol methine carbon). The signal at 072.18 
ppm was further correlated to C-8 and C-9, this confirmed that the secondary hydroxyl 
group was most likely to be at C-7. Therefore C-6 and·c-7 were assigned at 030.06 
and 72.18 ppm respectively. 
In an abietane skeleton, the isopropyl group is typically found at C-13, and the tertiary 
hydroxyl group was located at C-13 on this basis. C-13, C-15, C-16 and C-17 could 
be assigned from the cross-peaks observed for Me-16 and Me-17 in the HMBC 
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spectrum. C-14 could be readily assigned from the HMQC spectrum as the two H-
14's were shown to be simple doublets with Jgem = 16.67 Hz. C-11 and C-12 could 
then be assigned from the correlations observed on the HMBC spectrum for H-14. 
However, close examination of the literature data revealed the incomplete assignment 
of the 1 H NMR spectrum and some uncertainty about the stereochemistry at C-13. In 
the literature57 this was assigned on the basis of comparison of 13C spectral data with 
that of related structures 47 and 50, as well as from conformational considerations. 
Details of the argument presented by these authors are summarised as follows: 
The authors first noted that an analysis of the pimaradienes (47) suggested that 
irrespective of the stereochemistry at C-13, ring C adopted a half-chair conformation 
48 rather than the alternative 49. This was deduced inter alia from the difference in 
the 13C chemical shifts for the methyl carbons C-17 in 47a and 47b (323.5 and 28.2 
ppm respective), implying that the one was pseudo-axial and the other pseudo-
equatorial. They assumed that this conformation was favoured as it minimizes non-
bonded hydrogen interactions between H-lP and H-1 lp, H-lP and H-lla also C-20 
and H-1lp58• 
17 
47a 47b 
12 
~8 14 II 9-v:_ 
48 
.. 
l13 ~ .. 
a 
a: a =Me; ~ = C2H3 
b: a = C2H3; ~ =Me 
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49 
They then extended this argument to lbozol, assuming that ring C would also adopt 
conformation 48 for similar reasons as discussed for pimaradienes (47). Analysis of 
the 13C chemical shift for the isopropyl methine carbon (C-15) should therefore by 
analogy reveal the stereochemistry at C-13 in lbozol, with the pseudo-axial methine 
carbon further upfield than the pseudo-equatorial one. Since only one stereoisomer of 
lbozol was available, they used as a model (4)-terpinenol (50) where the isopropyl 
group was assumed to be mostly equatorial. In this compound the isopropyl methine 
carbon was found at 036.6 ppm which was c.a. 2 ppm downfield from the 
corresponding carbon in lbozol (C-15, 034.7 ppm), and this, they suggested, was 
evidence that C-15 in lbozol was pseudo-axial and therefore an a-substituent, and the 
-OH group therefore~. While there is some merit in this argument it did not provide a 
proof of stereochemistry. 
* indicates a possible signal reversal 
50 
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Since a few large crystals of Ibozol were obtained on recrystallization, one suitable 
crystal was submitted for single crystal x-ray diffraction in order to confirm the 
stereochemistry. The following results were obtained: 
The x-ray crystal structure of 45 clearly showed that the stereochemistry at C-13 was 
P-OH and a.-isopropyl and that it crystallized with the 13P-OH group axially oriented 
as shown in Figure 10. There are two independent molecules in the asymmetric unit. 
It is interesting to notice that examination of the bond lengths, bond angles and torsion 
angles showed that the two molecules are in two slightly, but significantly, different 
conformations. This is an unusual phenomenon for small molecules, although another 
example of this unusual characteristic is found in the crystal structure of cholesterol. 
Table 16 lists all the torsion angles for the two molecules A and B and differences 
observed between the two molecules. It was clear that significant differences in the 
torsion angles occtir mainly in rings B and the side chains of the two molecules. It 
was suspected that these two molecules do not have much energy differences, i.e. they 
are equally stable. The packing diagram, as shown in Figure 11, shows that the 
molecules pack in sheets, with their hydrophobic faces together. They are held in 
place by strong hydrogen bonding between hydroxy moieties, which is evident from 
the following Q ... Q distances (in A, the numbers in the brackets are the standard 
deviations). Normally, an Q ... Q distance of 2.6 - 2.8 A can be regarded as a 
significant hydrogen bonding, although weak hydrogen bondings can be observed for 
an Q ... Q distance of up to 3.0 A. 
2.766 (0.010) 07B - 07 A 
2.734 (0.009) 07A - 013B 
2.748 (0.010) 013B - 013A 
2.832 (0.010) 013A - 07B* 
* indicates a different molecule B 
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Figure 10 Crystal structure of 45 
Figure 11 Packing diagram of the crystal of 45 
Figure 12 Stereo view of the crystal structure of 45 
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Figure 12 shows the stereo view of the crystal which can be seen by any standard 
stereo viewer. 
Table 16 Torsion angles comparison for molecules A and B of 45 
Ring fragment of molecule Torsion angle Torsion angle A 
in molecule A in molecule B 
C 10-C l-C-2-C3 -59 -60 1 
Cl-C2-C3-C4 57 57 0 
A C2-C3-C4-C-5 -48 -49 1 
C3-C4-C5-Cl0 49 49 0 
C4-C5-CIO-Cl -51 -56 5 
C5-C 10-C l-C2 51 57 6 
C5-C6-C7-C8 39 40 1 
C6-C7-C8-C9 -15 -9 6 
B C7-C8-C9-C10 12 1 11 
C8-C9-C 1 O-C5 -31 -24 7 
C9-C 1 O-C5-C6 54 56 2 
C 1 O-C5-C6-C7 -60 -68 8 
C8-Cl4-Cl3-Cl2 -48 -47 1 
Cl4-Cl3-Cl2-Cl l 57 54 3 
c C13-Cl2-Cl l-C9 -41 -34 7 
Cl2-Cl l-C9-C8 12 9 3 
Cl l -C9-C8-C 14 -0.5 -0.4 0.1 
C9-C8-C 14-C 13 20 20 0 
Cl6-Cl5-Cl3-Cl2 180 -66 246 
Side Chain Cl 7-Cl5-C13-Cl2 56 59 3 
Cl6-Cl5-Cl3-Cl4 -60 64 124 
Cl 7-Cl5-Cl3-Cl4 176 -171 347 
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Having established the stereochemistry at C-13, complete assignments of the 1H and 
13C NMR spectra were possible with the aid of the HMQC and HMBC spectra. These 
assignments are shown in Tables 17 and 18; 
Table 17 1H NMR spectrum assignment of 45 
proton o(ppmt, multiplicity+ 
. 
proton o(ppm)11, multiplicity+ 
' 
. 
andJ(Hz) and J(Hz) 
. 
·. H-la 1.05, ddd0 H-12 ·. < 1.59 >* 
~.H-lp 1.75 H.,,J4a .. : 2.32, d, J = 16.67 Hz 
· H-2. 1.47, 1.61 H-14P 2.12, d, J = 16.67 Hz 
' 
H-3a 1.14, ddd, J = 14.5, 14.5, 
,: 
H-15 1.68, septet, J = 6.91 Hz 
.. .. 
4.0Hz 
. H-3P 1.41 .Me-16 0.91, d, J = 1.29 Hz 
-· . 
.. 
H':'5 1.16 Me-17 0.93, d, J = 1.39 Hz 
.. 
·· .. H-6 1.44, 2.12 Me':'18 0.88~ s 
H-7a 4.00 Me-19 0.86, s 
· H-11 < 2.08 >* Me-20 1.05, s 
0 indicates multiplicity was deduced from the shape of the cross-peak in the HMQC 
spectrum and spin coupling considerations, therefore J values were not available in 
that case 
* indicates mean values 
+ indicates multiplets were assumed wherever multiplicities were not stated 
11 indicates the assignments for H-14a and H- l 4p, Me-16 and Me-17 and Me-18 and 
Me-19 were interchangeable 
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Table 18 13C NMR spectrum assignment of 45 in o(ppm) and literature data 
Carbon 45 Literature Carbon·· 45 Literature 
data .. data 
37.05 37.2 
.. 
c-n ~ ':. 21.04 20.9 C-1 
C-2 18.91 18.9 C-f2 31.82 31.7 
C-3 41.39 41.4 0-13 72.11 72.3 
. .. 
. 
C-4 33.02 33.0 .. C-J4 · 35.66 35.3 
. . 
C-5 49.63 49.6 . C'!lS .. 34.17 34.7 
.; 
' C-6. 30.06 30.1 C-1,6 . 16.66 16.7 
C-7-
' 72.18 71.4 C.:17 16.77 16.8 
C-8 126.76 126.8 C.;,18 33.02 33.0 
· 'C-9 141.76 141.7 C-19 .. 21.60 21.6 
«:-10 38.40 38.4 C-20. 20.24 20.2 
·. 
A challenge in the assignment of the 1 H spectrum arose from the overlapping signals 
in the region ol.00 - 2.50 ppm. Detailed analysis of the HMQC spectrum revealed the 
peak shapes and multiplicities of the individual spin systems. For example, Figure 13 
shows the sub-spectrum generated for C-3, which resonated at 041.39 ppm as 
confirmed by the HMBC spectrum and was associated with the proton signals at o 1.14 
and 1.41 ppm. In the sub-spectrum, the signal at o 1.14 ppm was revealed as a ddd 
with coupling constants 14.5, 14.5, and 4.0 Hz consistent with one geminal coupling, 
one vicinal antiperiplanar coupling and one vicinal synclinal coupling. By viewing 
the perspective structure and Newman projection of ring A in Ibozol (shown in Figure 
14), it was clear that of H-3a and H-3p, only H-3a meets the requirements. The 
coupling pattern ofH-3a is shown in Figure 15. 
M - qU1,.....lDU1 
"' M <llQ' lD M - C'\I 
0 "' 
<llQ' <llQ' 0 0 M 77 M ..._ C\J CD CD "IQ' O'I 
..... "' 
,.....l.01111111"'1 
"' "' 
~ ~ <llQ' 'llQ' <llQ' 
I I \\I! I 
.... ----
2. 0 !.B 1.6 •. ~ I. 4 1.2 ,~ 1.0 0.8 0.6 
Figure 13 Sub-spectrum of C-3 of 45 
20 H-2~ 
-4 
H-3a 
Figure 14 Perspective structure and Newman projection of ring A of 45 
Figure 15 Coupling pattern of H-3a of 45 
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Therefore the signal at 81.14 ppm was assigned as H-3a. The shape of the cross-peak 
shown on the HMQC spectrum for H-3a and C-3 complemented the assignment, as 
shown in Figure 16 (right). Having assigned the one signal as H-3a, the other signal 
shown on the sub-spectrum with 81.41 ppm would then be H-3~. The signal for H-3~ 
was not as well resolved as that for H-3a. This was consistent \\1th its coupling 
pattern which arose from a geminal coupling to H-3a and two vicinal synclinal 
couplings to H-2a and H-2~. The two vicinal synclinal couplings were small as the 
dihedral angles were ca 45°. The shape of the cross-peak for H-3~ and C-3 \Vas 
consistent with an incompletely resolved ddd, with one large coupling constant of c.a. 
15.5Hz (see Figure 16, left). 
Figure 16 Cross-peaks ofH-3a and H-3~ of 45 
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Using this approach, the two diastereotopic protons on C-1 and C-3 could be 
distinguished. . With the aid of the HMBC spectrum, the assignments of 1H and 13C 
NMR spectra could be confirmed to be unambiguous. The connectivities of various 
protons with carbons are listed in Table 19. 
Table 19 HMBC experiment results of 45 
Connectivities observed 
C-2, C-5, C-10 
C-3, C-5 
C-1, C-3, C-4, C-5 
C-4, C-5 
C-1, C-2, C-5, C-10 
C-1 C-4 C-6 C-7 C-10 
' ' . ' '· . 
C-4, C-5, C-7, C-8, C-10 
C-8, C-9 
C-8 C-9 C-12 
' ' 
C-9, C-11, C-13, C-14, C-15 
C-7 C"-8 C-9 C-12 C-13 C-15 
' , ' ' ' 
C-13, C-14, C-16, C-17 
C-13 C~l5 C-17 
' ' 
C-13, C-15, C-16 
C-3, C-4, C-5, C-19 
C-3, C-4, C-5, C-18 
C·l, C-2, C-5, C-9, C-10 
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3.2.4. Structural Elucidation of Compound 51 
Compound 51 was present in both fractions U and V as a nunor constituent. 
However, it persistently eluted together with 44 on silica gel chromatography. After a 
few attempts at purifying 51 by gravity column failed, HPLC-UV was chosen to 
separate these two compounds as they both show characteristic absorption properties 
as shown in Figure 1 7. By using suitable gradient eluting solvent systems containing 
H20 and CH3CN, it was possible to separate 44 and 51 completely. The HPLC 
chromatogram is shown in Figure 18. A semi-preparative column was used in order to 
inject up to 10 mg of sample for each run. By optimising both solvents composition 
and flow rate, efficient separation could be achieved with minimum time. 
51 was obtained as a white crystalline compound with m.p. 187-189°C. Close 
examination of various spectroscopic data and literature suggested 51 to have the 
following structure. Details of the structural elucidation are given below. 
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Figure 18 HPLC chromatogram of 44 and 51 
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HREIMS of 51 showed a molecular ion at m!z = 346.1794, which corresponded to the 
molecular formula C20H260s. A fragmentation peak appeared at m/z 328 (i.e. M+ -
H20) indicating that there was at least one hydroxy group present in the molecule. 
The 1H NMR spectrum of 51 (Appendix, spectrum 29) showed the presence of 4 
methyl groups including an isopropyl group as indicated by the two 3-proton doublets 
at 81.26 and 1.28 ppm. Six distinct protons signals appeared in the region 82.80 -
9.90 ppm including: one methine proton singlet at 82.80 ppm; two proton singlets at 
85.26 and 5.95 ppm, typical of protons attached to oxygenated carbons; one septet at 
83.30 ppm which could be assigned to the isopropyl methine proton; one aromatic 
proton singlet at 87.34 ppm and one aldehyde proton singlet at 89.88 ppm. By 
comparing the spectroscopic data of 51 with literature data, 51 was identified as 
cariocal, a seco-diterpene previously isolated from Coleus barbatus59 which also 
belongs to the Labiatae family. This is the first time that cariocal is reported to be 
present in Tetradenia riparia. 
In the literature, the authors described how they determined the structure of cariocal to 
be 51 instead of 52, since by interpreting only 1H and 13C NMR spectra (Appendix, 
spectrum 30), there was no direct indication of which was the correct structure. The 
experimental support for structure 51 came from oxidation of cariocal methyl-ether 
(53) to lactone (54) which showed in its 1H NMR spectrum deshielding effects on H-
5, H-20 and Me-18, comparable to those observed on oxidation of acetyl enmein (55) 
to lactone (56)60. 
52 
53 
AcO 
oxidation 
~ 
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54 
H 
•' 
55 Z = "OH 
56 z = 0 
In this study, the structure, as well as full 1H and 13C NMR spectra assignments were 
confirmed by the HMQC and HMBC spectra (Appendix, spectra 33 and 34). The 
cross-peak expected to be observed in order to confirm the structure of 51 rather than 
52 was between H-20 and C 11 which was a three bond correlation through a 
heteroatom - oxygen. The results of the HMBC experiment are shown in Table 20. 
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Table 20 HMBC experiment results of 51 
·Pro toll 
.. Connectivities observed ' 
·H-5 .. C-4, C-6, C-9, C-10, C-18, C-19, C-20 ,,. 
H-7 . C-8, C-9 
-
H-14 . 
' 
~ ' ; C-7, C-9, C-12, C-15 
'" 
-. . ~~ •,., 
., ,., 
•.. 
~ 
·:n-20· ~ ~\~" "t' . ~ • .. ..,.~ C-6, C-9, C-10, C-11 
.. 
. . 
'Me-16 .. . .. C-13, C-15, C-17 ., .. ' 
.. 
·P.· 
. Me-17. "' C-13, C-15, C-16 
. 
. Me-18 o'''l. C-3, C-4, C-5, C-19 ; ~~ 
c "•.-
-· -~\Me~19 ·;• ~-.. .. C-3, C-4, C-5, C-18 
" 
-
... 
From Table 20, it is clear that only H-20 correlates to Cl 1, therefore the structure of 
cariocal was successfully confirmed to be 51 by spectroscopy. In the literature, there 
is uncertainty about the assignments of C-9 and C-13. From the HMBC spectrum, it 
was clear that C-9 (5133.67 ppm), appeared at higher field than C-13 (5135.48 ppm) 
as H-5, H-14 and H-20 all showed correlations to the carbon signal at 5133.67 ppm, 
whereas Me-16 and Me-17 both showed correlations to the carbon signal at 5135.48 
ppm. Also, in the literature, complete 1 H assignments were not available, but by 
perfonning a HMQC experiment, secondary protons in ring A could be assigned 
completely. Table 21 lists the full assignment of 1H NMR spectrum and Table 22 
shows the 13C NMR spectrum assignment and the literature data is listed for 
comparison. 
J=l3.88, 
13.88, 5.85 Hz 
1.67, m 
J=13.16, 
* indicates mean values 
# indicates J values were not available 
51 literature 
data 
29.70 29.69 
18.64 19.39 
37.51 .38.37 
30.68 31.08 
56.45 56.72 
101.91 101.82 
191.13 191.50 
124.15 124.66 
133.67 136.11 * 
56.57 56.90 
*, # and +indicate assignments interchangeable 
1.26, d# 
1.28, d# 
1.12, s 
51 
144.41 
143.88 
135.48 
129.17 
26.96 
. 22.46+ 
22.19+ 
32.06 
22.98 
114.52 
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literature 
data 
145.63 
144.88 
135.17* 
128.55 
27.47 
22.86# 
22.58# 
32.39 
23.31 
114.81 
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3.2.5. Preparation and Structural Elucidation of an Analogue (61) of 7a-
Hydroxyroyleanone (41) 
In an earlier study of the antimalarial activity of T. riparia as discussed at the beginning 
of the chapter, 7a-hydroxyroyleanone (41) was isolated from the active fraction of the 
stems extract and was found to be the most active compound against P. f a/ciparum in 
vitro (ICso = 3.40 µg/ml) in the plant. It was also found to be cytotoxic (with ICso 
values against WHCOl and NIH-3T3-MDR 1.41 and 1.51 µg/ml respectively). Since 
a significant amount of 41 was available from the extract, it was thought that it would 
be of interest to prepare structural analogues for evaluation of structure-activity 
relationships. Apart from the obvious transformations possible such as esterification, 
oxidation of the secondary alcohol and dehydration to create an additional double 
bond, the Diets-Alder reactivity was chosen for further study. From the range of 
possible dienes, cyclopentadiene (57) was chosen for the initial study. In theory, eight 
products would be expected as there are two potential dienophiles present in 41 and 
each could produce four products i.e. those arising from a- and P-face addition of 
cyclopentadiene in both exo- and endo- orientations. 
2 
3 
18 
41 
OH 16 
17 
+ 0 ? __ _,..,~ product 
57 
Scheme 2 
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An interesting precedent is the reaction of the benzoquinone (58) and trans-P-ocimene 
(59) which was performed in the context ofa total synthesis of (+)-Perovskone (60) as 
shown in Scheme 361 : 
58 
60 Perovskone 
Scheme 3 
The authors noted that on the basis ofNMR studies of St. Jacques and Vaziri62, which 
showed that benzocycloheptenes favour a chair conformation, the preferred 
conformation of quinone 58 should be cup-shaped with the a-face readily accessible, 
and therefore the diene would add from the a-face. The bulky isopropyl group was 
thought to control the regiochemistry of this cycloaddition. While the C rings of 41 
and 58 are the same, there are distinct differences in the A and B rings of the two 
molecules such as the absence of a double bond at the ring A - ring B junction in 41, 
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the number of carbons in ring Band the presence of Me-20 and the 7a-OH in 41. It 
would therefore be expected that the C-8-C-9 double bond in 41 would be less 
accessible than the corresponding one in 58. 
The reaction shown in Scheme 2 was therefore attempted. At first, the reaction was 
carried out at room temperature without the addition of the catalyst, Bf3.EtiO. 
However, no reaction product was observed. In the second successful attempt the 
reaction mixture was cooled to 0°C before the addition of the catalyst, and the reaction 
mixture was then allowed to warm to room temperature with stirring until completion. 
Two products were obtained in 80% yield. After purification by column 
chromatography, the major product (61) was isolated as a colourless glassy compound. 
MS showed a molecular ion at rn/z = 398. Significant fragmentation peaks appeared at 
rn/z = 380 (i.e. M" - H20) and rn/z = 365 (i.e. M" - H20 - Me) similar to those 
observed in the parent structure (41). 
The 1H and 13C spectra (Appendix, spectra 35 and 37) showed features consistent with 
a product of cycloaddition at the C-12-C-13 double bond. The most significant feature 
was the upfield shift (c.a. 0.90 ppm) of the isopropyl methine proton (H-15), 
suggesting it was no longer attached to an unsaturated carbon. Further evidence came 
from the upfield shift of the C-12 resonance in the 13C spectrum from o 151. 1 ppm to 
862.13 ppm. In contrast, the 1H chemical shift of H-7f3 remained virtually unchanged 
at o4. 70 ppm, suggesting that the C-8-C-9 double bond was intact. In addition, new 
olefinic signals were observed at 85.58 and 5.81 ppm. Starting from this preliminary 
evidence, it was possible to carry out a complete assignment of the 1H and 13C NMR. 
spectra with the aid of various 2D experiments, which led to the identification of 61 as 
7a, 12f3-dihydroxy-3'f3,6'f3-methano-3' ,4' ,5' ,6' -tetrahydrobenzo[l 2, 13]-(13a)-abieta-
8, 4' -diene-11, 14-dione with stereochemistry as shown. 
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The proton and carbon signals in rings A and B were shown to have similar chemical 
shifts with the starting material. From the signal at 84. 70 ppm for H-7f3, the protons 
H-6a. and H-6f3 could be identified from the COSY spectrum (Appendix, spectrum 38) 
to be 81.70 and 2.12 ppm respectively. C-6 could then be identified at 826.32 ppm 
from the HJ\.1QC spectrum (Appendix, spectrum 39). The geminal dimethyl groups at 
C-4 were recognized from the common HMBC (Appendix, spectrum 40) correlations 
observed for signals at 80.91 and 0.96 ppm, suggesting that these were methyls 18 and 
19. Of these only the signal at 80.91 ppm showed NOESY (Appendix, spectrum 41) 
correlation to the methyl signal at 81.16 ppm, suggesting that these were Me-19 and 
Me-20 respectively. After assigning the methyl groups, C-1, C-3, C-4 and C-5 were 
readily assignable from the HMBC spectrum, therefore, H-1, H-3 and H-5 could be 
assigned from the HJ\.1QC spectrum. C-2 was assigned by comparing the 
spectroscopic data of 61 with the starting material. The assignment of H-5 led to the 
identification of C-9 and C-10 from the HMBC spectrum as H-5 was shown to be long 
range coupled to these two carbons. This completed the assignment for rings A and B. 
A spin system could be identified in the 1H NMR spectrum which corresponded to the 
new bridge ring system fused at C-12 and C-13. The single methylene group in this 
system was identified from the fact that the protons resonating at 82.00 and 2.47 ppm 
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were correlated in the HMQC spectrum to one carbon at 835.54 ppm, and this was 
assigned as the bridge C-3". 
The two olefinic protons appearing at 85.58 and 5.81 ppm were shown to be multiplets 
which were assigned as H-4' and H-5'. 
The two protons in the 3"methylene group were shown to be coupled to H-3' in the 
COSY spectrum and this in tum had a strong 4-bond coupling (W-coupling) to H-6'. 
From the 1H, 13C and COSY data it was not possible to unambiguously distinguish 
between H-4' and H-5', and between methine protons H-3' and H-6'. However, 
information from the NOESY spectrum was helpful in this regard. The isopropyl 
methine proton H-15 showed a correlation to the signal at 82.90 ppm but not to the 
signal at 83.94 ppm, therefore, these two signals were assigned as H-3' and H-6' 
respectively. H-6' showed a correlation to the signal at 85.58 ppm which was 
therefore assigned as H-5'. 
These assignments were confirmed by the HMBC correlations in particular, H-3' 
showed a correlation to C-15 and H-6' showed a correlation to C-12. 
The remaining issue to be resolved was the relative oriention of the 4'-5' olefin and the 
methylene group in the bridged ring D, i.e., whether cycloaddition had taken place in 
endo- or exo- mode and from the a- or J3-face. The NOESY experiment provided 
evidence for the stereochemistry as discussed below. 
A correlation was observed between the 3" methylene protons and the methyl groups 
at C-16 and C-17. In addition, correlations between H-5' and H-5, and H-5' and H-la 
were observed. This suggested that the new ring has formed from the a-face with the 
olefin oriented towards ring A as shown in the perspective diagram in Figure 19. 
H 
7 
H 
H H 
~ 
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Figure 19 
Molecular modelling confirmed that the observed NOE's are possible since the new 
ring is folded under the original skeleton and is twisted so that only H-5' is within the 
range (3A) for observable through-space interactions. 
The observed atomic distances predicted by molecular modelling for selected pairs of 
atoms is shown below: 
H-5' - H-5 2.85 A 
H-5' - H-la. 2.28 A 
H-la. -H-5 2.41 A 
H~4' -H-5 3.67 A 
H-4' -H-la. 4.46A 
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Tables 23 and 24 summarise the assignments for 1H and 13C NMR spectra, whereas 
Table 25 lists the HMBC spectrum results. In Table 23; the multiplicities of H-la,-·H-
3a and H-5 were deduced from the shape of cross-peaks in the HMQC spectrum and 
spin coupling considerations, therefore J values were not available in those cases. 
Table 23 1H NMR spectrum assignment of 61 
1.23, ddd 
2.76 
1.48, 1.62 
1.15, ddd 
1.42 
1.63, t 
1.70 
o(ppm), multiplicity# and J(Hz) 
2.12, ddd, J = 11.34, 13.64, 9.24 Hz 
2.35, d, J = 3.60 Hz 
4.70, ddd, J = 9.24, 9.24, 3.00 Hz 
6.62, s 
2.21, septet, J = 7.00 Hz 
1.14, d, J = 2.00 Hz 
1.16; d, J = 2.00 Hz 
0.96, s 
0.91, s 
1.16, s 
2.90, ddd, J = 9.89, 9.89, 4. 73 Hz 
5.81 
5.58 
3.94 
:;:;:;:::=::;:;:;.;:;,;:;:;:;:;::1 2.00, 2.47 
*indicates assignments were interchangeable 
# indicates multiplets were assumed wherever multiplicities were not stated 
Table 24 13C NMR spectrum assignment of 61 
o(ppm) 
36.75 
18.66 
41.62 
40.64 
46.02 
26.32 
63.64 
140.46 
146.12 
34.44 
194.76 
62.13 
71.49 
Table 25 HMBC experiment results of 61 
C-4, C-6, C-9, C-10, 
C-11, C-13, C-14, C-16, C-17 
o(ppm) 
206.78 
28.78 
18.83 
18.83 
20.97 
32.90 
20.74 
40.07 
134.58 
130.41 
45.80 
35.54 
C-11, C-12, C-13, C-15, C-4', 
,. C-5', C-6', C-3" 
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Table 26 NOESY experiment results of 61 
Proton · NOESY's observed 
- . 
H-la ~· H-lp, H-2a, H-3a, H-5, H-5' 
.J! 
' H-lP 
.. 
H-la, H-2a, H-2p, OH-12 
. ; .. 
·. H-2a 
' 
··.: .. H-2P, H-3a 
-, 
.. 
H-2P H-2a H-3P Me-19 
' ' ·: 
- -H-3a ~· ... H-la, H-2a, H-3p, H-5, Me-18 
. 
H-3P . H-2p, H-3a, Me-18, Me-19 
-H-5 
-
'° H-la, H-3a, H-5', Me-18 
' "' . 
H-6a - H-6p, H-7P, Me-18 
H-6~ · · H-6a, Me-19 
OH-7a H-7P 
' 
H-7P H-6a, H-6p, Me-20, OH-7a 
· OH-12 . H-lp, Me-16, Me-17 
H.,.15 H-3', Me-16, Me-17 
' 
Me-16 . H-15, H-3', H-3", OH-12 
; 
Me-17 H-15, H-3', H-3", OH-12 
Me-18 ; H-3a, H-3p, H-5, H-6a, Me-19 
Me-19 ., H-2P H-3~ H-6~ Me-18 Me-20 
' ' ' ' 
Me-20 H-lp, H-2p, H-6p, Me-19 
H-3' H-15, H-3", Me-16, Me-17 
H.,.4' H-5', H-3' 
H-5' H-la, H-5, H-4', H-6' 
H-6' H-5' 
H-3" H-3', Me-16, Me-17 
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The formation of the product indicates that the reactivity of dienophile at C-8 and C-9 
was lower than that at C-12 and C-13, this might be due to the presence ofMe-20 and 
OH-7a. at the~- and a.-face respectively of the starting material making the dienophile 
at C-8 and C-9 less accessible. It is interesting to notice that the molecular modelling 
of the starting material shows that the Cring was folded upwards, i.e. the two carbonyl 
groups were pointing up, this might have contributed to the accessibility of the a.-face. 
Also, it is suggested that the BF3.EtiO is more likely to form a complex on the J3-face 
which would also favour a-attack of the diene. 
The success of the above Diets-Alder reaction has encouraged further modification of 
the structure which may contribute to the study of structure-activity relationships. 
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3.3. Conclusion 
As a continuation of the previous work done at the Pharmacology Department, UCT50, 
fractions identified with antimalarial activity . from the traditional plant Tetradenia 
riparia were further fractionated. Fractions U and V were the two fractions identified 
and subjected to fractionation in order to isolate possible antimalarial principle(s). 
Four compounds (42, 44, 45 and 51) were isolated and identified. 1H and Be NMR 
spectra of all four compounds have been fully assigned by using the various ID and 2D 
NMR techniques. 
7a.-hydroxyroyleanone (41) was previously isolated from an active fraction of T. 
riparia and identified to be the active principle of the plant. One analogue (61) was 
prepared for 41 by reacting 41 with cyclopentadiene (57). The structure of 61 was 
deduced from its various ID and 2D NMR spectra. The 1H and Be of 61 were fully 
assigned by the aid of the COSY, HMQC, HMBC and NOESY spectra. 
The ICso values of all the compounds isolated and prepared are listed in Table 27, 
which shows that Ibozol ( 45) is the most active antimalarial compound present in T. · 
riparia extracts. 
Table 27 The ICso values of compounds 42, 44, 45, 51 and 61 
1Cs0(µg/ml) 
>100 
10 
2.8 
23 
17. 
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CHAPTER FOUR 
XEROPHYTA RETINERVIS 
4.1. Introduction 
Apart· from the two plants investigated in this project, Passerina obtusifolia and 
Tetradenia riparia, one novel flavonolignan was obtained from the methanol extract 
of Xerophyta retinervis which was supplied by Noristan. Records for X retinervis in 
the Noristan database reveal that the plant has reported antimicrobial, antiulcer, 
central nervous system and anti-inflammatory activity. 
Although there was no immediate access to bioassays for evaluating the reported 
activity of X retinervis, the extract was subjected to investigation due to the following 
reasons: 
(1) there was a large quantity of material available ( c.a. 20g of extract); 
(2) the antimalarial activity of this plant had not been investigated previously. 
X retinervis was formerly known as Vellozia, and is also known as: monkey's tail, 
bobbejaanstert, olifantstert and besembos. "Xerophyta" is from the Greek, meaning a 
plant that loves dry areas, and is structurally adapted for growth with a limited water 
supply, and retinervis is Latin, meaning reticulately nerved63. Its interesting to 
mention that X retinervis is known as a "resurrection plant" because of its desiccation 
tolerance: it is one of several plants capable of surviving severe drying or desiccation. 
X retinervis belongs to the family Velloziaceae which consists of fibrous perennials 
with dwarf and tufted stems covered with numerous leaf-bases64. 
The flowers of X retinervis are usually blue or mauve, rarely white (see Figures 20 
and 21) with capsules covered with rough hairs65• X retinervis occurs on rocky hills 
around Pretoria and Johannesburg, as well as in the western and eastern Transvaal and 
Swaziland63. 
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Figure ~O Flowers of Xerophyta retinervis (blue or mauve) 
.. 
Figure 21 Flowers of Xerophyta retinervis (white) 
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The methanol extract contained a major component (62) which was obtained as a 
precipitate from the extract when dissolved in EtOAc later purification and 
recrystallization gave a yellow, crystalline compound with m.p. 247 - 248°C. 
HREIMS of 62 showed a molecular ion at m/z = 506.1224 which corresponded to the 
molecular formula C21H2201o(W = 506.1213). 
4.2. Results and Discussion 
4.2.1. Structural Elucidation of Compound 62 
The proposed structure of 62 resulted from an analysis of a complete set of NMR data, 
as well as identification of the products of acetylation and deacetylation of 62. 
A preliminary analysis of the 
1
H, 13C, DEPT and COSY NMR spectra (Appendix, 
spectra 42, 43, 44 and 45) revealed the following information: the 1H NMR spectrum 
showed four isolated spin systems, three in the downfield region typical of aromatic 
signals, and the fourth in the region o4.0 - 5.0 ppm, typical of protons attached to 
oxygenated aliphatic carbons. Closer examination of the coupling patterns suggested 
the presence of sub-structures A', B', C' and D' (Figure 22). The substitution pattern 
of the aromatic rings (A', B' and C') was deduced from the presence of ortho- (ca. 8.3 
Hz) or meta- (ca. 2.0 Hz) couplings (see Table 28). 
H H H J 
H H 
(A') (B') (C') 
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{D') 
Figure 22 
In addition there were five singlets indicating the presence of a methoxyl group (83.78 
ppm), an 0-acetyl group (82.04 ppm), an olefinic proton at a chemical shift typical of 
an a,P-unsaturated carbonyl system (86.82 ppm), and the remaining two in downfield 
positions (89.25 (broad) and 12.86 ppm) suggesting phenolic -OH groups. The 13C 
NMR and DEPT spectra confinned the presence of 13 protonated carbons, including 
two methyl, one methylene and 10 methine carbons. It also confinned the presence of 
a carbonyl carbon. At this stage it was necessary to establish the connectivity between 
the sub-structures shown as well as the nature and location of all 10 oxygen atoms in 
62. The foregoing infonnation accounts for 8 oxygens (1 methoxyl, 1 acetyl, 2 
phenolic, 1 carbonyl and the three additional oxygens in sub-structure D'). 
Acetylation of 62 (see Scheme 4) produced a tetra-acetate (63) as judged from the four 
acetyl proton singlets in the 1H NMR spectrum (Appendix, spectrum 48), confinning 
the presence of three additional hydroxyl groups. Compound 63 has been prepared 
previously, the spectroscopic data of 63 compares well with literature66. A 
deacetylation was also carried out (see Scheme 4) to gain further infonnation: this 
proved difficult by conventional methods due to the poor solubility of 62, but it was 
found that it did dissolve in large volumes of dry methanol and so was treated in this 
solution with methanolic sodium methoxide to achieve the deacetylation. The product 
(m.p. 261 - 263°C) was found to be identical by comparison of m.p. and spectral data 
to the known flavonolignan, hydnocarpin (64), identified previously in Hydnocarpus 
wightiana
67
• Table 31 shows the 13C NMR spectrum assignment of 64 (see also 
Appendix, spectrum 49) with literature data listed for comparison. This implied that 
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62 was a mono-acetate of this compound, and further 2D NMR experiments were 
carried out to determine the location of the acetate, and to fully assign the 1H and 13C 
spectra. 
The HETCOR spectrum (Appendix, spectrum 46) permitted the full assignment of the 
· protonated carbons in the sub-structures A', B', C' and D'. With these assignments in 
hand, the f™BC spectrum (Appendix, spectrum 47) could be used to fully assign the 
remaining carbons in each of the sub-structures from the connectivities listed in Table 
30. The way in which the different sub-structures were connected was then established 
from the following significant correlations in the HMBC spectrum: both H-2' and H-6' 
showed connectivity to C-2 , H-3 showed connectivities to C-2, G-4, C-10 and C-1', 
and both H-:6.and H-8 showed connectivity.to C-10. The following sub-structure (E') 
shown in Figure 23 could be obtained from these connectivities: 
H 
Figure 23 
The other part of the molecule was established as follows: both H-15 and H-19 were 
shown to be long range coupled to C-13; H-13 showed connectivities to C-12, C-14, 
C-15 and C-19; the two H-11 protons showed connectivities to C-12 and C-13; 
finally, the methyl group in OCOMe showed connectivities to C-11 and C-21. The 
following sub-structure (F') shown in Figure 24 was then obtained: 
.·""\'.~' 
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(F') 
Figure 24 
The two sub-structures E' and F' were joined as the chemical shifts of C-3' and C-4' 
(143.02 and 146.89 ppm respectively) suggested that they were connected to oxygens. 
X in sub-structure (E') was also assigned to oxygen as indicated by the chemical shifts 
ofC-9 and C-2 (0157.28, 162.66 ppm respectively). The chemical shifts of carbons 5, 
7, 16 and 17 (0161.35, 164.25, 147.38 and 147.71 ppm respectively) suggested that 
they are all directly bonded to oxygens which accounted for the presence of three -OH 
groups and one -OMe group in 62. 
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Scheme 4 
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The following are interesting features to notice: aromatic protons of ring C are more 
deshielded than those of ring E probably due to the adjacent oxygen atoms in ring D; 
the anti-relative stereochemistry at H-12 and H-13 was indicated by the value of 8.1 
Hz for 112-13; and the 1H signal for H-12 was observed as a multiplet due to additional 
coupling to the diastereotopic protons at C-11. 
Full assignments of the 1H and 13C NMR spectra of 62 are shown in Tables 28 and 29 
respectively. Table 30 lists the resuts for the HMBC experiment. 
Table 28 1H NMR spectrum assignment of 62 
Proton · o(ppm), Proton 
' 
o(ppm), 
,• 
... multiplicity and multiplicity and 
~. 
.. 
" ' 
. J(Hz) J(Hz) 
H-3 6.82, s H-12 
. 
4.6,m 
H-6 6.20, d, J = 2.08 Hz H-13 5.05, d, J = 8.12 Hz 
H-8 6.53, d, J = 1.98 Hz H-15 7.03, d, J = 1.92 Hz 
. H-2' ~ 7.65, d, J = 2.35 Hz H-18 6.81, d, J = 8.12 Hz 
H-5' 7.07, d, J = 8.54 Hz H-19 6.87, d, J = 8.12 Hz 
· H-6; 7.58, dd, J = 8.55, OMe ' . ' 3.78, s 
2.35 Hz 
.. 
H-11 's 4.03,m OCOMe 2.04, s 
Table 29 13C NMR spectrum assignment of 62 
.·Carbon· 
. '"';: < , .·• S(ppm) 
C-2 
·C-4 
·: ·c.;s·: 
~ .. '"' . 
,.'.C.;6. ' . 
·· ·: ·c.:.1: 
. ' ~ ~. ' • "! 
. ' . 
... 
.. ' 
162.66 
103.99 
181.69 
161.35 
98.87 
164.25 
~ 
. ,... . ~ 
:. :-Q-2' ' . : 
94.07 
157.28 
103.73 
123.89 
114.91 
143.02 
146.89 
117.59 
.• 
C-3' 
. C-4'. 
~ ' 
· , ·• C-5'. · 
.. · '~ .... - ·~· 
* indicates assignments interchageable 
Table 30 HMBC experiment results of 62 
. Pro ion . :·. Connectivities observed 
. H-3 
~ 
C-2, C-4, C-10, C-1' 
H-6 C-5 C-7 C-8 C-10 
' . ' ' 
R·8 C-6, C-7, C-9, C-10 
H-13 C-12, C-14, C-15, C-19 
H-15 C-13, C-16, C-19 
H-18 C-14, C-16, C-17 
H-19 C-13, C-15, C-17 
·c~14 
.C-15 · •' _,,;, .; 
,T''' 
,,,- . ' ·~ {i~~- .~ 
·. . :S~.~? , . ,, . , ·: .. r 
d'.':J~ : ... ,,,,; .. :'.·~:. 
f • .~ • . • ~ 
C-"19 . ~ -..a . '"·~. 
.. ~ .•· -· "' 
C-20· ··~ 
C-21 · ·- '• 
J :-.... °' ~~ .... ' 
. ! . . .. · ~ ... -'. ~ ... ' 
I • C-~2 .. ·' ·· .. ' ' . 
¥ ·i~ 
. ' 
S(ppm) 
120.13 
62.41 
74.89 
76.25 
126.01 
111.72 
147.38* 
147.71 * 
115.42 
120.63 
55.65 
169.98 
20.38 
·.Proton ,.:, . . Connectivities observed 
' H-2' . C-2, C-3', C-4', C-6' 
H-5' C-1 ', C-3', C-4', C-6' 
H-6' C-2, C-2', C-4' 
H-11 's C-12, C-13 
·OMe C-16 
OCOMe· C-11, C-21 
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Table 31 13C NMR assignment (in ppm) of 64 and literature data 
64 Literature 64 
164.29 
103.91 
181.74 
157.32 
98.91 
161.40 
93.69 
162.89 
103.75 
123.67 
114.53 
143.63 
data 
164.2 
103.8 
181.6 
157.3 
98.5 
161.4 
93.9 
162.8 
103.8 
123.6 
114.6 
143.6 
147.07 147.2 
* and # indicate assignments interchangeable 
4.3. Conclusion 
117.49 
119.88 
60.05 
76.34 
77.98 
126.93 
111.83 
147.62* 
147.12* 
115.33 
120.58 
55.72 
Literature 
data 
116.7 
119.3 
59.6 
76.4 
78.1 
127.0 
110.9 
147.7# 
147.0# 
115.4 
120.6 
55.8 
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A new flavonolignan, 11-0-acetyl hydnocarpin (62) has been isolated from Xerophyta 
retinervis in significant amounts. The fraction of the crude extract containing this 
component had been shown to inhibit stress-induced ulceration in rats at Noristan. 
Antimalarial test of 62 showed an ICso value of 12 µg/ml. 
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CHAPTERS 
EXPERIMENTAL SECTION 
5.1. General 
5.1.1. Characterisation of Compounds 
1H and 13C NMR spectra were recorded at room temperature on one of the following 
three spectrophotometers: (1) a Varian VXR-200 (200.057 MHz)~ (2) a Varian Unity 
(399.951 MHz) or (3) a Bruker AMX-400 (400.136 MHz) in deuteriochloroform 
unless otherwise stated. The 1H chemical shifts (8) are given in ppm relative to the 
signal of tetramethylsilane (TMS, o = 0.00 ppm) or the residual chloroform (8 = 7.25 
ppm) in deuteriochloroform. The 13C spectra were recorded with proton noise 
decoupling and chemical shifts (in ppm) were assigned relative to the central line of the 
deuteriochloroform triplet at 677.09 ppm. 
Infrared spectra were recorded in Nujol or dichloromethane using a Perkin Elmer 
Paragon 1000 FT-IR spectrometer. 
All melting points were determined on a Reichert Jung hot stage microscope melting 
point apparatus- and are uncorrected. 
Mass spectra were recorded on a VG micromass 16 F mass spectrometry at 70 e V 
with accelerating voltage of 4KV. High resolution masses and mass spectra were 
recorded at the Mass-Spectrometry Unit of the Cape Technicon. 
All fractionations and reactions were monitored by TLC (see below). Detection was 
achieved by one of the following methods: 
(I) using an ultra-violet lamp (wavelength 254 nm and 365 nm), 
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(2) by spraying the TLC plates with a 1 % solution of eerie ammonium sulphate in 
H2S04 followed by heating at ca 100°C or 
(3) by spraying the TLC plates with a 2.5 % solution of anisaldehyde in H2SO.JEtOH 
followed by heating at ca 100°C. 
Analytical TLC was performed using Merck TLC aluminium-backed silica gel 60 
sheets; layer thickness 0.2 mm, employing one of the following solvent systems (in 
the appropriate optimized ratios): 
Petroleum ether : EtOAc 
CHCh: EtOAc 
CHCh : EtOAc : Petroleum ether 
Four different types of column chromatography was employed. Flash chromatography 
was performed in either a large (10 cm diameter) or a small (4 cm diameter) glass 
column packed with silica gel 60 (PF254 containing gypsum, for preparative layer 
chromatography, Merck Art. 7749). The third column was a 1.5 cm diameter glass 
column packed with silica gel 60 (0.040 - 0.053 mm particle size, 230 - 400 mesh 
ASTM, Merck Art. 9385) in whi.ch elution proceed by gravity. The fourth column 
comprised of a 0. 75 mm diameter pasteur pipette packed with silica gel 60 (less than 
0.063 particle size, finer than 230 mesh ASTM, Merck Art. 7729). The above solvent 
systems were also applicable to the column separations. 
HPLC was performed on a LCIO (Shimadzu) apparatus with reverse phase C18 silica 
column and a diode array spectrophotometer (Shimadzu) as detector. Distilled water 
(Millipore) and HPLC grade Acetonitrile (Merck) in the appropriate optimized ratios 
were used as eluting solvents. 
5.1.2. Solvents 
Petroleum ether: CP (chemically pure) grade, distilled 
EtOAc: CP (chemically pure) grade, distilled 
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CHCh: CP (chemically pure) grade, distilled 
C6H6: AR (analytical reagent) grade, distilled and dried over Na wire. 
5.2. Passerina obtusi{olia 
The ground plant material of Passerina obtusifolia was supplied by the Pharmacology 
Department at UCT. The plant material was divided into two parts, leaves and stems 
576.53 g and 703.90 g respectively) which were then subjected to Soxhlet extraction 
with petroleum ether followed by ethanol. The gums obtained from these four 
extractions were then subjected to bioassay from which the petroleum ether extract of 
the stems (18.04 g) was found to have the highest activity. Further fractionation of 
this active extract by flash chromatography produced 11 fractions (fractions A to K). 
The one fraction identified with activity (fraction J, 1.20 g) was then chromatographed 
by flash chromatography, and further purification was achieved by employing the 
third and fourth column as described above. Two compounds were isolated from this 
active fraction (compounds 30 and 32). 
20(29)-Lupene-3a,28-diol (30) 
Jl ...... H 
Crystallized from petroleum ether/EtOAc as white crystals (312.5 mg); m.p. 210 -
213°C (lit.68C NMR, see Table 4; HREIMS: M + 442.3798, C30H5002 requires 
442.3811; EI-MS m/z (rel.int.): 442 (M+, 29), 424 (M+ - H20, 19), 411 (24), 234 
(18), 220 (19), 207 (51), 203 (46), 189 (100), 135 (63). 
llO 
20(29)-Lupene-3a., l 6f3,28-triol (32) 
Crystallized from petroleum ether/EtOAc as white crystals (8. 7 mg), m. p. 215 - 2 l 7°C; 
IR, Vmax 3383, 1617, 1378, 1259; 1H NMR, see Table 7; 13C NMR, see Table 8; 
HREIMS: M" 458.3756, C30JLs03 requires 458.3760; EI-MS m/z (rel.int.): 458 {M", 
3), 440 (M" .. H20, 92), 422 (M" - H20 - H20, 30), 409 (42), 391 (39), 385 (33), 220 
(18), 219 (18), 207 (51), 203 (30), 201 (39), 189 (100), 187 (68). 
5.3. Tetradenia riparia 
Fractions U and V (0.65 and 1.04 g respectively) from T. riparia extract were obtained 
from Mr. D.R. Dodds, Department of Pharmacology, UCT50. The fractions were 
chromatographed by employing flash chromatography on a small glass column, later 
chromatographic separation of the fractions by employing the third and fourth column 
yielded four compounds (compounds 42, 44, 45 and 51). 
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3 P-Hydroxy-20(29)-lupen-28-oic acid ( 42) 
J.! ... H 
'•. 
H 
0 
HO 
Crystallized from petroleum ether/EtOAc as off-white crystals (4.3 mg), m.p. 274 -
277°C (Lit.68 275 - ·278°C); 1H NMR, see Table 11; 13C NMR, see Table 12; 
HREIMS: ~ 456.3587, C3ofLis03 requires 456.3603; EI-MS m/z (rel.int.): 456 
~, 5), 438 (M+ - HzO, 31), 423 (~ - HzO - Me, 27), 410 (9), 248 (15), 220 (14), 
219 (13), 207 (37), 203 (27), 189 (100). 
5-Hydroxy-4' ,6, 7-trimethoxyflavone ( 44) 
OMe 
MeO 
MeO 
OH 0 
Crystallized from CHCh as yellow needles (16.5 mg), m.p. 186 - 188°C (Lit.68 188°C) 
IR, Ymax 3439, 1658, 1589, 1511, 1495, 1357, 1126; 1H NMR, see Table 14; 13C 
NMR, see Table 15; MS: M+ 328, molecular formula C1sH1606; EI-MS m/z (rel. 
int.): 328 (M+, 100), 313 (M+ - Me, 89), 299 (23), 285 (24), 256 (20), 181(25),167 
(32), 153 ( 42). 
I 12 
8-Abietene-7p,l 3P-diol( 45) 
Crystallized from petroleum ether/EtOAc as colourless crystals (150 mg), m.p. 147 -
150°C (Lit.68 146 - 150°); 1H NMR, see Table 17; 13C NMR, see Table 18; MS: M+ 
= 306, molecular formula C20H3402; EI-MS m/z (rel.int.): 306 ~. 4), 273 (16), 255 
(5), 227 (5), 217 (8), 202 (4), 189 (35), 187 (17), 173 (9), 119 (63). 
Cariocal (51) 
Crystallized from petroleum ether/EtOAc as white crystals (8.0 mg), m.p. 185 - 187°C 
(Lit.68 186 - 189 °C); 1H NMR, see Table 21; 13C NMR, see Table 22; HREIMS: 
M+ 346.1794, C20H260s requires 346.1780; EI-MS m/z (rel.int.): 346 (M+, 99), 328 
(M+ - H20, 73), 313 (16), 300 (56), 285 (59), 271(28),257 (40), 149 (46), 69 (61). 
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Preparation of 7a.-Hydroxyroyleanone (41) Analogue: 7a.,12P-dihydroxy-3'P,6'P-
methano-3' ,4' ,5' ,6'-tetrahydrobenzo[12, 13]-(13a.)-abieta-8,4'-diene-11, 14-dione (61) 
7a.-Hydroxyroyleanone (41) (100 mg, 0.30 mmol) was dissolved in dry benzene (1 
cm
3) with stirring. Once the solids dissolved, the solution was cooled to 0°C. Freshly 
distilled cyclopentadiene (57) (0.25 cm3, 3.03 mmol) was added dropwise to the 
solution. One drop of BF3.0Et2 was added to the reaction mixture as catalyst. The 
reaction mixture was left stirring for 48 hrs before working-up which was as follows: 
Sat. NaHC03 (15 cm3) was added to the reaction mixture, and the resulting mixture 
extracted with EtOAc (3 x 10 cm3). Finally, the resulting EtOAc (30 cm3) was 
extracted with NaHC03 (10 cm3) and H20 (2 x 10 cm3). The organic phase was dried 
over anhydrous MgS04 filtered and the volume of solvent reduced in vacuo to afford 
the crude product which was then chromatographed on silica gel (10 g) eluting with 
EtOAc-petroleum ether (5 : 95) yielding 61 as a colourless glassy compound (73 mg, 
73 % yield). 
1H NMR, see Table 23; 13C NMR, see Table 24; MS: ~ 398, molecular formula: 
C2sH3404; EI-MS m/z (rel. int.): 398 (~. 51), 380 (M+ - H20, 46), 365 (5), 355 
(25), 338 (100), 333 (21), 323 (5), 319 (12), 316 (20), 315 (24), 310 (33), 269 (12), 
195 (24), 123 (33), 66 (72). 
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5.4. Xerophvta retinervis 
The crude leaves methanol extract of X retinervis was obtained from Noristan. 
Compound 62 was obtafhed as a precipitate from this extract when dissolved in 
EtOAc. Later purification gave a yellow crystalline compound. 
11-0-acetyl hydnocarpin (62) 
HO 
0 
o:co~ 
··· (XOMe 0 ··· .. ~ 
I ~ OH 
Crystallized from THF as yellow crystals, m.p. 247 - 248°C; IR, -Vmax 3406 (OH), 
2953, 1738 (C=O), 1614, 1585 (C=C), 1305; 1H NMR, see Table 28; 13C NMR, see 
Table 29; HREIMS: ~ 506.1224, C21H22010 requires 506.1213; Microanalysis 
found: C, 64.01, H, 4.46 %, C21H22010 requires C, 64.03, H, 4.38 %; EI-MS m/z 
(rel.int.): 506 (~, 18), 447 (6), 179 (18), 147 (10), 137 (7), 124 (7). 
Tetra-acetylated Hydnocarpin (63) 
AcO 
0 y-"oAc 
0 ) ........ (X ~[ OMe 
~ OAc 
Compound 62 (30 mg, 0.059 mmol) was dissolved in pyridine (2 cm3) then acetic 
anhydride (2 cm3) was added and the mixture refluxed for 2 hrs. Then the reaction 
mixture was cooled to 0°C, MeOH (5 cm3) added, then toluene (5 cm3) before 
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evaporating off the solvents under reduced pressure. Further portions of toluene (5 
cm3) were added to remove final traces of pyridine and removed under reduced 
pressure. Finally, portions of MeOH (7 cm3) were added to remove toluene and 
solvents removed under reduced pressure. The product was chromatographed on 
silica gel. Elution of 63 with petroleum ether - EtOAc (50: 50) gave 7 mg of 63, a 
yellow crystalline compound with m.p. 195 - 197°C (Lit.66 196 - 198°C). 1H NMR 
(200 MHz): 87.53 (d, J = 1.93 Hz, H-15); 7.43 (dd, J = 8.54, 2.10 Hz, H-6'); 7.34 (d, 
J = 2.25 Hz, H-8); 7 .10 ( d, J = 8.59 Hz, H-19); 7 .08 ( d, J = 8.50, H-18); 6.99 (H-2'); 
6.97 (H-5'); 6.84 (d, J = 2.28 Hz, H-6); 6.58 (s, H-3); 5.00 (d, J = 8.00 Hz, H-13); 
4.60 (m, H-12); <4.40>* (m, H-11); 3.86 (s, OCHJ); 3 singlets at 2.44, 2.35 and 
2.33 ppm corresponded to the 3 Ar-0-COCH1; 2.09 (s, aliphatic-OCOCHJ) 
Deacetylated derivative of 62 - 64 (Hydnocarpin) 
HO 
O~OH 
0 ) ........ oc ,...-::OMe 
. I 
~ OH 
Compound 62 (25 mg, 0.049 mmol) was dissolved in dry MeOH (100 cm3). A 
catalytic amount of 0.1 M MeONa was added and the reaction vessel left overnight at 
room temperature. The solvent was removed by evaporation and the product purified 
on silica gel to give 64 as a yellow crystalline compound with m.p. 261 - 263°C (Lit.66 
262 - 264°C). The 13C NMR data of 64 corresponded well with that of the known 
compound hydnocarpin (see Table 31 ). 
* indicates mean 8 value. 
\ 
) 
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